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Cancer is becoming a global epidemic in recent times and can affect different organs in 
the body and even more worrying is that they do not have a common cause. Several 
factors have been implicated in the onset and spread of cancers, one of which are the 
metalloproteinases (MMPs). The MMPs utilize the same strategy they employ in normal 
physiological processes in pathology, thus creating a dilemma in the development of 
cancer inhibitors. The MMP-2 and MMP-14 (aka MT1-MMP) proteins have been 
discovered to be present at the forefront of many cancers and can lead to poor prognosis 
in the patient, due to their ability to migrate to and invade across barriers, eventually 
leading to metastatic spread. 
This study was based on the overexpression of the intracellular variant of MMP-2 (MMP-
2ic) and the knockdown of MMP-14 in HSC-3 cells and analyzing for their migratiive and 
invasive abilities. Although successful overexpression of the MMP-2ic clones was 
achieved, the knockdown of MMP-14 was not as conclusive and thus migrative and 
invasive study cannot be concluded upon.
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1.  INTRODUCTION 
1.1 The Matrix Metalloproteinases 
Matrix metalloproteinases (MMPs) are members of the endopeptidase family that are 
able to cleave the proteins of the extracellular matrix [1] and other substrates both in 
normal physiological processes as well as under pathological conditions[2-6]. They are 
mostly involved in tissue remodeling and have been shown to be conserved across the 
animal kingdom [7, 8].They can be secreted, membrane-bound or intracelullarly located 
[9]. In general, they form a family of closely related zinc-dependent endoproteinases. 
MMP discovery was dated back to the early 1960’s, when Gross and Lapiere were trying 
to ascertain the reason behind the loss of tails in tadpoles during metamorphosis and 
this led to the discovery of the very first MMP, MMP-1[10].  MMPs are excreted by a 
wide range of connective tissues which include fibroblasts, endothelial cells, osteoblasts, 
macrophages, lymphocytes and neutrophils. There are about 23 members of the MMP 
family which share some specific structural and functional components [11]. 
 
In essence, the basic structure of the domain of the members of the MMP family could be 
said to be consisted of a hydrophobic signal peptide responsible for secretion by guiding 
the MMP into the RER ( rough endoplasmic reticulum) during synthesis; a propeptide 
domain that maintains the enzyme in its latent form; a catalytic domain consisting of the 
highly conserved zinc binding site; as well as a hemopexin-like C-terminal domain, PEX, 
that is connected to the catalytic domain through a flexible region called the hinge 
region. The zinc binding site in the catalytic center is made up of the HEBXHXBGBXHS 
motif where H is histidine, E is glutamic acid, B is bulky amino acid, X is variable amino 
acid and S is serine [12] .The PEX domain is present in most of these MMPs and is 
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involved in MMP activation through its ability to bind endogenously to TIMPs (Tissue 
inhibitors of MMPs) and some MMP substrates [5, 11]. 
 
 
Figure 1: the Basic structure of Matrix Metalloproteinases [11] 
 
MMPs have the ability to degrade both extracellular and non-extracellular matrix 
proteins and as a result, can influence physiological processes [13] such as bone 
morphogenesis, early embryogenesis and development, menstrual cycle, wound healing, 
remodeling processes etc. [14, 15] by the means of their effect on cell proliferation and 
differentiation, survival, invasion, migration, cell-cell interaction, angiogenesis, 
inflammation, apoptosis etc. [16, 17].Through their ability to cleave and release cell 
surface proteins, latent growth factors and cytokines embedded in the extracellular 
matrix and as a result of their normal physiological functions [11, 18], MMPs are tightly 
regulated at several points which include activation, transcription, inhibition of the 
activation and compartmentalization[19, 20]. MMPs have been shown to be expressed in 
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tumor and neoplastic stromal cells as well as in fibroblasts and inflammatory cells [17, 
21]. They have been able to give rise to various pathological conditions as a result of 
their proteolytic activities and thus, their inherent proteolytic activity and possible 
dysregulation have been implicated in certain pathological conditions such as arthritis, 
arterosclerosis, nephritis and even cancers such as acute lymphoblastic leukemia, 
chronic B lymphocytic leukemia (CLL), acute myeloid leukemia, Hodgkin’s and non-
Hodgkin’s lymphoma etc [11, 22]. MMPs can also be classified by means of the 
substrates they act on, into Gelatinases (A and B) which degrade gelatin eg MMP-2 and 
MMP-9; Collagenases, that are able to degrade collagen eg MMP-1, MMP-8 and MMP-13; 
Stromelysins eg MMP-3, MMP-10 and MMP-11and Matrilysins eg MMP-7 and MMP -25; 
others include MMP-12 and MMP-26[23, 24] [3, 11]. 
 
The gelatinases, occurring as gelatinase A (MMP-2) and gelatinase B (MMP-9), differ 
from the rest of the MMPs in that they harbour the CBD (collagen binding domain) 
within their catalytic domain. The catalytic domain in turn, is made up of repeats of 
fibronectin II type and enables the binding of collagen, elastin, fatty acids, 
thrombospondins etc [25, 26]. 
 
1.2 MMP-2 STRUCTURE AND FUNCTION 
MMP-2s, Matrix metalloproteinase-2, AKA gelatinase A, are extracellular matrix proteins 
and as members of the MMP family, are zinc-dependant endopeptidases which have the 
ability of cleaving the proteins of the extracellular matrix under normal physiological 
conditions as well as in pathological condition [3]. The MMP-2 is usually secreted as a 
72kDa inactive zymogen, proMMP-2 and its activation occurs when the prodomain is 
cleaved, giving rise to a 65kDa active form [11]. MMP-2 activation can be achieved by 
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several processes which include activation by MMPs-1, -7, activated protein C, thombin , 
MMP-14 interaction as well as autoactivation by collagen α2 VI chain. Out of the above 
mentioned processes, the proMMP-2 is mostly activated on the cell surface through its 
complex formation (via its PEX domain) with the MT1-MMP (via its catalytic domain) 
and TIMP-2 [27] and both MT1-MMP and TIMP have been shown to regulate their 
activities [28]. Once activated, MMP-2s acquire the ability to degrade/or cleave the 
components of both extracellular and non-extracellular matrix proteins and this in turn 
can lead into several processes that can be implicated in both normal physiology and of 
course pathological processes[29].  Activated MMP-2s are able to promote cell 
migration, invasion and angiogenesis[30], which in turn promotes tumor progression 
and metastatic spread[31, 32] by working in concert with the extracellular matrix, 
growth factors such as  chemokines, adhesion molecules and of course the basement 
membrane[33-36]. It is the actual deterioration of the basement membrane that leads to 
metastasis. Although MMP-2’s were thought to directly degrade the basement 
membrane, they were later found to perform indirect cell signaling functions by 
influencing the bioavailabilty and bioactivity of molecules which target specific cell  
growth, migration, inflammation and angiogenesis receptors [11, 37]. Gelatinases, 
amongst other things have been the most implicated MMPs in cancer due to the fact that 
they are usually overexpressed in a lot of malignant tumors and their expression and 
activities are indicative of the aggressiveness of a tumor [38, 39], as well as a sign of 
poor prognosis/ survival [40-44] 
 
Although MMPs are basically extracellular proteins, some MMPs such as the MMP-1, 
MMP-2 and MMP-11 can be intracellularly located and may possibly act on intracellular 
proteins[4, 9, 27, 33, 45-47]. While much is known about the extracellular mechanisms 
10 
 
of MMP-2, it is not the case with the intracellular mechanisms. However, they have been 
implicated in cardiac pathologies [46, 48, 49]. The intracellular MMP-2 in the heart 
muscles have been shown to be directed by oxidative stress in a mechanism that does 
not require the proteolytic removal of its propeptide [33, 50]. This usually occurs in 
cardiovascular pathologies such as ischemic reperfusion injury [33, 51]. Acute changes 
in the myocardial contractile function have also been shown to be caused by the 
intracellular localization of MMP-2s and their ability to cleave specific proteins 
necessary for myocardial contractility [9, 50].  
 
The existence of intracellular MMP-2 can be explained by the occurrence of about 3 
MMP-2 isoforms [46]. While the first generally known “classical” full length MMP-2 
undergoes the “proper” secretion pathway through the translation of a full-length MMP-
2 mRNA that gets exported to the extracellular space via secretory vesicles in the latent 
form [46], there yet exists two others that do not get to enter the extracellular space. 
This is basically due to the fact that they lack the signal peptide that directs them to the 
extracellular space and are hence trapped in the intracellular environment. The 
pathways that have been proposed for their intracellular “entrapment” are as thus: A 
fraction of the first intracellular variant tends to escape the secretory pathway following 
its translation and hence localizing to sarcomeric proteins as well as troponin I. In the 
case of the second intracellular variant, an N-terminal truncated mRNA transcript is 
generated when a latent promoter in the first intron of the MMP-2 gene is activated 
during hypoxia and redox stress. The resultant MMP-2 is a 65 kDa MMP-2 isoform 






                  
              Figure 2: The three MMP-2 isoforms and their processing, localization and activation [46] 
 
 
1.3  MMP-14 STRUCTURE AND FUNCTION 
MMP-14 aka Membrane-type 1 Matrix metalloproteinase (MT1-MMP) are members of 
the MMP family that are located on the cell surface, being bound to the cell membrane 
via a TM domain or GPI anchor [11]. While the secreted MMPs such as the gelatinases 
have repeats of the fibronectin type-II- like domains which interact with gelatin and 
collagen, the Membrane type MMP (MT-MMP) which consist of 6 members, MT1-MMP 
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to MT6-MMP, are anchored to the cell surface either through a C-terminal 
transmembrane domain (TM-1) or the glycosylphosphatidylinositol (GP1) anchor [11]. 
This makes this group of MMPs unique and in addition to that is the fact that they house 
a furin recognition motif between their prodomains and their catalytic domain, as well 
as being processed by proprotein convertases eg furin, in the secretory pathway [11].  
They are thus, mostly located outside the cell in active form, where they also carry out 
their function. The MT1-MMP functions in the activation of pro-MMP-2 and in the 
degradation of some macromolecules of the extracellular matrix such as collagen I, II 
and III, laminin-1and laminin-5, fibronectin, vitronectin, fibrin, cartilage proteoglycans, 
aggrecan and by so doing, promotes cell migration and invasion [52]. MT1-MMPs are 
inhibited by TIMPs 2-4 and are insensitive to TIMP-1, a feature shared among all MT-
MMPs except for MT4-MMP. In the absence of their inhibitor, MT1-MMPs are rapidly 
autodegraded into a 44kDa form and thus, active MT1-MMPs are usually of very low 
concentration on cell surfaces as a result of their rapid turnover rate [34]. 
                            
 Figure 3:The pathway of MT1-MMP presentation on the cell surface [34] 
 This in essence explains the occurrence of MT1-MMP in complex with their inhibitor 
such as TIMP-2 (which is the most common inhibitor) on cell surfaces. The MT1-MMP-
TIMP-2 complex, eventually serves as a receptor for pro-MMP-2 on the cell surface. 






                      
Figure 4: Determination of MT1-MMP substrate choice by TIMP-2 [34] 
 
Collagen has been shown to be the most important substrate that is degraded by the 
MT1-MMP during the course of cell migration [53], being the most abundant ECM 
component in the human body and thus posing as a huge barrier to migrating cells. 
Structurally the collagen is made up of three long left-handed helical polypeptides that 
are looped with one another in a right-handed configuration [54]. These in turn form 
polymeric fibrils at 37°C under a neutral pH and are then deposited into the tissue as an 
insoluble matrix. As a result of its triple helical state, the collagens are mostly resistant 
to degradation by most proteinases at a neutral pH, but under the same condition, are 
susceptible to collagenolytic enzymes that are present in the MMP family [54]. The MMP 
family members that exhibit collagenolytic activities are MMP-1, MMP-8, MMP-13, MMP-
2 and MMP-14 (MT1-MMP). Out of these classical collagenases, only the MT1-MMP is 




The extracellular matrix performs several functions in an organism, serving as a glue 
that enables the holding together of cells, giving structural functions to organs through 
the provision of framework for tissues, serving as signaling molecules, as well as playing 
the role of a scaffold that is necessary for the survival, differentiation and functioning of 
a cell [18, 54]. Thus, while the ECM is a scaffold to migrating cells, it can at the same time 
act as a migration barrier [54]. As a result of their function in body tissues, the turnover 
of the ECM is highly regulated since its excessive degradation or lack of it can affect 
cellular behaviours in particular and as such, give rise to tissue/organ functional defects 
[18, 55].   
 
MMPs are usually overexpressed in various malignant tumors with a strong correlation 
established between their overexpression and tumor aggressiveness, tumor stage as 
well as prognosis [56, 57]. Thus the presence of MMP activity around a tumor is an 
indication of increased tissue remodeling and degradation. The tumor molecular 
environment had been shown to be favorable for the activation of MMPs and in fact the 
observation of activated MMP-2 in various tumors informed the line of thought on the 
presence of pro-MMP-2 activators in tumor tissues. This line of thought eventually led to 
the discovery of the MT1-MMP, which was shown to activate pro-MMP-2 on cellular 
surfaces. MMP-2 and MMP-14 are able to work in concert to promote angiogenesis and 
metastasis in cancer due to their roles in tissue remodeling via basement membrane 
degradation [58]. 
 
Tumor cell invasion is proposed to undergo a three-step event such as adhesion to ECM 
structures, proteolytic degradation of the ECM and migration of the tumor cells into the 
degraded area [56]. In order to mediate tissue remodeling and promote invasiveness in 
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malignancies, the MMPs would have to be in their active form. Several mechanisms have 
been shown to activate pro-MMP-2 and these basically occur by the proteolytic cleavage 
of the prodomain. Examples of these processes include the TIMP-regulated activation by 
the MT1-MMP, activation by other MT-MMPs and activation through the interaction of 
the pro-MMP-2 with elastin, heparin and CD151 [55]. The most important of these 
processes and in reference to the present study is the activation of the pro-MMP-2 by 
the MT1-MMP-2 which also shows the relationship between the two MMPs in cell 
migration and invasion. The relationship between the MMP-2 and the MT1-MMP can be 
seen in its activation and function. 
 
It has been suggested that proMMP-2 can be activated by MT1-MMP in the presence of 
TIMP-2, by the formation of a ternary complex between the molecules, in which TIMP-2 
acts as a bridge between the MT1-MMP and pro-MMP-2[59, 60]. The ternary complex is 
in such a way that the N-terminal region of the TIMP-2 is linked to the MT1-MMP, while 
its C-terminal region is linked to the hemopexin region of the proMMP-2. In order to 
finally activate the pro-MMP-2, there is the need for another MT1-MMP to cleave it, 
giving rise to an intermediate 64 kDa molecule that eventually becomes processed into 
the fully active 62 kDa form by autocatalysis [34]. The net activity of MT1-MMP and 
MMP-2 is regulated by the concentration of TIMP-2 and other inhibitors in a complex 
manner [34, 42]. Other TIMPs such as TIMPs-1, -3 and -4 are also able to regulate the 
activation of pro-MMP-2 via MT1-MMP and TIMP-1 has been shown to keep the pro-
MMP-2 in its inactive intermediate form, thus preventing its autoactivation. 
 
Following their activation by MT1-MMP, MMP-2 acts by breaking down tissue and 
bringing about remodeling during tumor invasion, they get intravasated into the blood 
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circulation, they become extravasated and migrate to sites of metastasis by promoting 
angiogenesis [56]. While MMP-9 has been initially thought to be the most important 
MMP in cell invasion and metastasis as a result of their overexpression in cancer cells as 
well as their induction by numerous cytokines, growth factors and products of 
oncogene, MMP-2 has been shown to be involved in a lot of cancers [61]. There has been 
a suggestion that an increase in MMP-2 activity actually contributes to the very first step 
in metastatic spread [62] [38], through the promotion of angiogenesis [63], tumor cell 
infiltration across the basement membrane as well as invasion into the circulation [64, 
65]. Invasiveness of both normal and neoplastic cells has been shown to be promoted by 
MMP-2 and it has been shown that pro-MMP-2 that are overexpressed in either serum 
or by stromal fibroblasts in cancer tissues are somewhat activated on the cancer cells by 
the MT1-MMP. Thus a correlation has been made between the overexpression of MMP-2 
to that of MT1-MMP in the presence of TIMP-2 [66]. 
 
1.4 MMP-2 and MMP-14 in Cell Migration and Invasion 
Cell migration and invasion are complex processes involving the ECM, proteinases, 
chemokines, adhesion receptors and the basement membrane [67]. MMPs play 
significant roles under normal physiological condition part of which includes wound 
healing, in which there need for the migration, proliferation, ECM disposition as well as 
remodeling [68, 69]. This process enables the recruitment of immune cells and growth 




Figure 5: MMPS in wound healing and angiogenesis [20] 
 
In pathology, it seems like the same mechanism as that in wound healing seems to be 
employed to facilitate the invasion of tumor cells from the primary tumor site to 
metastatic sites [69, 71-73].Thus the basic promigratory machinery that are employed 
in normal cells happen to be retained in tumor cells and their migration seems to be 
activated by the heightening of promigratory events in the absence of counteracting stop 
signals [67, 72, 74]. The imbalance of these signals enables the continuous migration 
and invasion of the cancer cells, causing the tumor cells to expand across tissue barriers 
and eventually leading up to metastasis [72]. The presence of MT1-MMPs in tumor cell 
lines have been shown to be a driving factor in the penetration of the basement 
membrane as well as in the invasion of cells through the interstitial type-1collagen 
tissues [60]. MT1-MMP are known to be accumulated at specialized ECM-degrading 
membrane protrusions on invasive cells known as the invadopodia [52, 71, 75] and in 
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addition to the MMP-2, have been found to be present in high amounts at tumor invasive 
fronts in which they breakdown the matrix [38, 54, 69]. 
 
Figure 6: MT1-MMP and Invadopodia and Lamellipodis formation for cell migration [54] 
 
As the most common physiological activator of the MMP-2, a deficiency in MT1-MMP has 
been seen to lead to the production of very minute levels of active MMP-2 in mice [34]. 
Again, while a knock-out of MMP-2 in mice has led to phenotypic changes such as small 
stature, blunted tumour-related angiogenesis and abnormal alveoli in the lungs; a 
knock-out of MT1-MMP has been associated with highly defective angiogenesis, skeletal 
development and eventually death shortly after birth, around a couple of weeks [34, 76]. 
This is an indication of the level of importance of this MMP. Worse still is the effect of the 
double-knockout of both MMPs, in which the mice were born with abnormal blood 
vessels, immature muscle fibres and respiratory failure, dying as soon as they are born 
[14, 34].  This again goes to show that though these MMPs are important in the 
maintenance of homeostasis, they are on the other hand implicated in pathology such as 





As cancer cells migrate/invade, there is the need for the formation of new blood vessels 
(angiogenesis) which enhances tumor growth and metastasis [53, 78, 79].  Under 
normal physiological conditions, the development/establishment of vascular supply and 
modelling [2] is of critical importance for growth, maturation and tissue maintenance 
[30] and this happens to be the case with metastasis [80], where the primary tumor 
establishes its own blood supply derived from the host cell [30]. Vascular proliferation 
and vessel formation are influenced by certain factors such as acidic and basic fibroblast 
growth factor, TGF and TNF alpha [29]. Although the MMPs are directly involved in 
tissue remodelling, they have been shown to also carry out this function through their 
interaction with cytokines and growth factors [35, 79].Through their degradative impact 
on the ECM, the gelatinases tend to release or generate bioactive molecules that in turn 
influence the growth of the tumor [35] [81]. This can be seen as the release of 
cryptic/hidden information from the ECM and basement membrane that can give rise to 
the migration of cells and thus, metastasis [11]. 
In the case of metastatic breast cancer for example, the migration of breast epithelial 
cells has been shown to be induced by MMP-2 activity in which case the MMP-2 cleaves 
and regulates the function of laminin-5 (Ln-5), which is a component of the ECM [22, 
61]. Cells have the tendency to attach to the ECM substrates with the help of the integrin 
receptors and the effect of the gelatinases and plasmin on selected components of the 
basal membrane, shows that activated gelatinase cleaves the Ln-5 subunit at residue 
587, exposing a possible pro-migratory cryptic site which is able to provoke the motility 
of cells as against adhesion. On the other hand, the cleavage has the potential to cover up 
a site that inhibits cell motility. As a result of the fact that pro-migratory cryptic sites do 
not promote adhesion indicates the influence of MMP-2 proteolytic activity in the 
provision of signaling mechanisms to initiate cell migration in mammary gland 
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morphogenesis [22]. This was seen as the case in the enhanced migratory response to 
gelatinase A-modified Ln-5 in MCF-7, which is a neoplastic epithelial cell line [22, 82]. 
 
Although MMP-2 is generally known to exert its function in the extracellular 
environment, this project was aimed at looking at the intracellular subtype of MMP-2 
(MMP-2-ic) and its possible role in the migration and invasion of tumor cells since it has 
been shown to be expressed in cancer cells. For this purpose, oral squamous cell 
carcinoma cell line, HSC-3, was used to overexpress the intracellular MMP-2, since it was 
not expressing either the extracellular or intracellular MMP-2. The same cell line, that 
has been shown to be expressing MMP-14 (MT1-MMP) was knocked-down for MMP-14 
after which the effects of the MMP-2 overexpression and the MMP-14 knockdown was 
analysed using the xCELLigence assay. 
At the start of the experiment, the expression levels of MMP-14 and MMP-2 was 
determined in wild-type HSC-3 cells (HSC-3wt) using the western blotting and SDS-
PAGE gelatin zymography techniques in both cell lysates and conditioned medium. 
The cells were then overexpressed for Intracellular MMP-2 (MMP-2ic) by first 
determining the optimal concentration of the G418 antibiotic that was required to kill 
the HSC-3 cells, followed by the transformation of the DH5α competent bacteria with the 
pM02-MMP2ic (Z5731) and pReceiver-M02 ( empty vector) plasmids respectively . The 
colonies expressing the plasmids were selected on LB plates with ampicillin followed by 
purification and verification of the plasmid insert by sequencing and restriction enzyme 
cleavage after which they were used to stably transfect the HSC-3 cells using G418 as the 




The overexpression of MMP-2ic was confirmed by western blotting for the 
determination of the protein and RNA transcript respectively, using two colonies 
respectively from the EV transfectant and the overexpression transfectant. For the 
MMP-14 knockdown, the E.coli DH5α competent bacteria was first transformed using 4 
MMP-14 shRNA constructs including a scrambled control. Colony selection was done on 
LB medium plates (with 100µg/ml ampicillin) followed by plasmid purification. The 
concentration and purity of the purified plasmid was determined on the Nanodrop after 
which the plasmids were used to transiently transfect HSC-3 cells for MMP-14 
knockdown out of which the construct that gave the best knockdown was used for stable 
transfection, to select for mixed bulk clones expressing mMP-14 knockdown with 
puromycin as the stable selection marker. 
Eventually, all the MMP-2 and MMP-14 cell clones were analysed for subcellular location 
by immunofluorescent staining and confocal microscopy; in situ zymography was 
employed on the FL-MMP-2 and EV control to analyse for gelatinolytic activity and 
finally, the HSC-3-EV, HSC-3-MMP-2ic, HSC-3-sc and HSC-3-MMP-14kd clones were 
compared in terms of cell migration and matrigel invasion, using the xCELLigence 
system. 
 
1.5  The shRNA Concept 
shRNAs are short hairpin RNAs that are utilized  in the RNA interference technology to 
bring about a knockdown/silencing of a gene, by targeting their mRNA. They are 
sequences of RNA (19-22nt) capable of making a tight hair-loop structure (4-11), similar 
to those in miRNA, and have the ability to degrade target RNA [83]. The in vitro 
expression of shRNA in mammalian cells is made possible through direct plasmid 
delivery, use of bacterial or viral vectors and the choice of method is dependent on the 
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cell’s “transfectability” [84]. The use of viral vectors (infection) has been associated with 
a much more successful knockdown of the target gene due to the long-term integration 
into the host genome [84]. The shRNAs are transcribed in the nucleus by either RNA pol 
II or modified polymerase III promoters of the expression vector that bears a short 
double stranded DNA sequence containing a hairpin loop and following their 
transcription, get exported to the cytosol where they get recognized by Dicer, an 
endogenous enzyme that cleaves them into duplexes of siRNA [83]. This endogenously-
derived siRNA oligonucleotide functions in the same manner as the exogenously-derived 
siRNA by binding to the target mRNA and loaded onto the RISC complex for target-
specific mRNA degradation [83], translational inhibition and heterochromatin formation 
[85-87]. 
 
1.6 The Principle of Gelatin Zymography 
The use of SDS-based Gelatin Zymography involves the use of denaturing, non-reducing 
conditions (SDS) for the separation and detection of proteins (gelatinases) [88-90]. 
Usually, SDS polyacrylamide gel electrophoresis is used to separate electrically charges 
molecules moving against an electric field in such a way that smaller molecules move 
more slowly than the larger ones. This is made possible when the anionic detergent in 
the protein sample preparation buffer, SDS, reacts with the polypeptide chains of the 
protein causing their linearization as well as imparting them with negative charges. The 
charges are evenly distributed per unit mass and this eventually results in their near 
exact separation on the polyacrylamide gel during electrophoresis.  
 
The gelatin chromatography technique is only different from the SDS-PAGE in the sense 
that gelatin is incorporated into the separating gel in which it co-polymerizes with the 
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acrylamide [91]. The separating gel thus functions as a matrix that allows for the 
detection of gelatinases through their degradation of the gelatin. During the 
electrophoresis, there is a denaturation of the MMP by the SDS and this gets partially 
renatured and activated during the washing step when the SDS is exchanged for 
Triton®-X100; the latent MMPs also get autoactivated at this stage without any cleavage. 
Eventually, during incubation in the appropriate incubation buffer, the concentrated and 
renatured MMPs digest the gelatin and the digestion can be detected as clear bands on 
blue background (undigested substrate) following staining with Coomassie blue. Gelatin 
zymography is a very sensitive and reliable technique for the detection of the 
gelatinases, detecting as little as 10pg amounts [4]. That notwithstanding, other MMPs 
such as MMPs-1,-8 and -13, but this could appear as very faint bands which become 
stronger when separation is done with the appropriate substrates for these MMPs such 
as casein and collagen. 
 
1.7 In situ Zymography 
In situ zymography is a method that can be employed in the detection and localization of 
enzymatic activity within cell culture or tissue sections [4, 21, 89, 92-94]. As a result of 
this, the enzyme in question has to be in its active form especially since they are 
secreted in their inactive pro-form and thus, this method detects only the active form of 
the enzyme. This gives a clear difference between the in situ zymographic technique as 
against that of the gelatin zymography in the sense that while the gelatin zymography is 
used in the detection of all forms of the enzymes such as pro- and active, the in situ 
method is more discriminatory with its affinity for only the active form. 
There are 3 types of in situ zymography: 
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- The photographic emulsion-based method in which tissue sections are immersed 
in silver-coated substrate containing photographic emulsion in which light 
microscopy is used in the detection of proteolytic activity. Thus substrate 
cleavage is detected as reduction in silver concentration which appear as white 
patches on a dark background [91]. 
- The fluorescently labelled method involves the coating of glass slides with 
fluorescent substrate followed by the mounting of tissue sections onto the slides 
and incubation. Detection is done under fluorescent microscopy in which 
proteolytic activity is observed as dark patches on a fluorescent background [91]. 
- The third method, the highly quenched substrate method, was used for this 
project due to its high sensitivity and ease of standardization. It involves the 
incubation of tissue sections or cell culture on glass slides, with a highly 
quenched fluorescently labelled substrate (DQ gelatin) and following fluorescent 
microscopy, proteolytic activity is detected as fluorescence against a dark 
background [91].  
 
Although ISZ has the advantage of determining the proteolytic activity of only the active 
enzyme in question, it has a disadvantage in that it measures the net activity of all the 
proteases that degrade the substrate. In essence, the specificity of the enzyme(s) for the 
substrate determines to a large extent, the measured enzyme activity and since most 
substrates have a large mileu of proteases, pinpointing the exact protease responsible 
for the enzyme activity can pose a difficulty. This can be controlled by the combination 
of ISZ with IHC or in situ hybridization, incorporation of inhibitors eg EDTA, specific 





1.8  xCELLigence 
The xCELLigence system uses the readout of impedance to noninvasively quantify the 
status of cells in real-time [95, 96]. This makes it possible to assess cell behavior such as 
adhesion, proliferation, migration, invasion as well as cytotoxicity, without any 
disruption to its natural environment [95, 97-101].This method has the advantage of 
enabling a continuous quality control of cells [96, 102]. The RTCA-DP instrument is 
made up of two components; the RTCA Control Unit and the RTCA DP Analyzer, with 
three stations which are integrated for the measurement of cell responses either 
individually or in parallel. The xCELLigence system makes use of two types of 
impedance-based 16-well plates such as the E-16 plate/E-Plate VIEW (for cellular 
assays) and the CIM-PLATE 16 (for migration and invasion assays). The plates are 
constructed in such a way that they are made up of a top and a bottom chamber. 
Beneath the top chamber are gold-plated microelectrode sensors.  
 
The cells are seeded on the top chamber of the plate and are able to move through the 
microporous membrane (of the TC) into the bottom chamber containing a 
chemoattractant such as FBS. The RTCA DP Analyzer and the plates containing the cells 
are placed in a CO2 incubator to attain normal cell culture conditions.  The adherence of 
cells to the microelectrode sensors leads to an increase in impedance which gets read-
off in real time by the xCELLigence RTCA DP instrument [97, 98, 102, 103]. The 
impedance readout is usually affected by several factors such as seeded cell number, 
adhesion and morphology and thus different cell lines will exhibit different proliferative 
patterns depending on the density seeded. Again, when cells are treated with cytotoxic 
compounds, each of the above features is uniquely affected, yielding unique Time 
26 
 
Dependent Cellular Response Profiles. The resulting response profiles will then be able 
to aid in the optimization of experimental conditions  such as seeding densities and  
time; they would made the elucidation of a compound’s mechanism of action possible; 




2. MATERIALS AND METHODS 
 
2.1 List of Materials 
                 
   
CELL CULTURE 
MEDIA  





Technologies, Carlsbad, CA 
   
OPTIMEM #31985-047. Gibco®Life 
Technologies, Carlsbad, CA 
  
Fetal bovine serum (FBS) #F7524. Sigma-Aldrich, Oslo, 
Norway 
  




5g Yeast Extract 
10g NaCl 
Make up to 1 litre with Milli-
Q water and autoclave 
  















1X Trypsin-EDTA #T3924. 0.5% Trypsin, 
0.2g/L EDTA. Sigma-Aldrich, 
Oslo, Norway 
   
Freezing Solution (Cells) FBS + 10% DMSO 
  
Freezing Solution (Cell 
supernatant) 
1M Hepes (pH 7.4) + 0.1M  
CaCl2 
  
Hydrocortisone # H6909. Sigma-Aldrich, 
Oslo, Norway 
  








Cat # 11668-027.Invitrogen 
Life Technologies, New-York, 
U.S.A 
  
Prestained ladder P/N 100006636. Invitrogen, 
Carlsbad, CA 
  
Magic marker Lot # 1030592 P/N LC5602. 
Invitrogen, Carlsbad, CA 
  
Biotin ladder #7716S. New England 
BioLabs, Ipswich,U.K   
  
1kb ladder # SM13311.Fermentas 
ladder Gene Ruler 1kb DNA 
ladder Plus. Thermo 
scientific, Oslo, Norway  
  
100bp ladder Fermentas Gene 
Ruler™100bp DNA ladder # 
SM 0321 
  
SYBR Green #330523. Qiagen, Hilden, 
Germany 
  
BSA #A9647. Sigma-Aldrich, Oslo, 
Norway 
  
BioRad Dc Protein 
AssayKit 
Reagent A: Cat # 500-0113 
Reagent B: Cat # 500-0114 





#27106. Qiagen, Hilden, 
Germany 
  
Nucleobond® Xtra Midi # 740 410 50. Macherey-




# 205313. Qiagen, Hilden, 
Germany 
  
Nde 1 Restriction enzyme Nde 1 R0111S.Ipswich, U.K 
  
Goat Serum Dako Lot # 00095732 code 




DQ Gelatin #D12054. Invitrogen, 
Carlsbad, CA 
  




4% PFA 0.4g PFA 
9ml Milli-Q water 
Adjust pH to 7.5 
1M NaOH 
1ml 10X PBS 
   




RIPA Buffer 25 mM Tris HCL pH 7.6 
150mM NaCl 
1% Triton x-100 
0.5% Sodium deoxycholate 
0.1% SDS 
Protease inhibitor (100µl/ml 
buffer) 
⃰  Sigmafast™ Protease inhibitor cocktail 
tablets, EDTA free (S8830) 
  
RNA PURIFICATION  
Cell Lysis Buffer 350µl RLT Buffer 
6 µl 3M DTT 
  
• Buffer RLT Lot # 142319059 
  
RNeasy kit  # 74134 
  





Equilibration Buffer 0.1M Hepes pH 7.5 
 0.05% Bri 
  
Washing Buffer 0.1M Hepes pH 7.5 
0.05% Bri  
0.5M NaCl 
  
Elution Buffer 0.1M Hepes pH7.5 
0.05% Bri  
0.5% DMSO 
WESTERN BLOTTING  
1x NuPAGE Running 30µl 20x MES SDS 
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Buffer (MES SDS) 570 Milli-Q water 
  
1xTBST 60ml 2.5M NaCl 
20ml 1M Tris pH 7.4 
1ml Tween 20 
Make up to 1 litre with Milli-
Q water 
  









NUPAGE Sample Buffer NP0007 Invitrogen   
  
Luminol Reagent Santa Cruz SC-
2048.Immunocruz 
  
Stripping solution Millipore® Reblot plus 





10x Buffer NEB Buffer 2 # B70025 
  
GELATIN ZYMOGRAPHY  
Electrophoresis buffer pH 
8.3 (10X) 
30 g Tris base 
144g glycine 
10g SDS (1% final 
concentration) 
+ up to 1 litre with Milli-Q 
water 
pH adjustment to 8.3 with 
conc HCL 
  
Separating gel buffer 
(0.5M Tris) 
0.605g Tris base 
0.04g SDS 
Milli-Q water to 10ml 
pH adjustment to 6.8 with 
conc HCL 
+100µl sodium azide  
  
Stacking gel buffer (1.5M 
Tris) 




Milli-Q water up to 100ml 
pH adjustment to 8.8 with 
conc HCL 
+ 100µl sodium azide 
  
Washing buffer 10 ml Triton X-100 
Up to 400ml Milli-Q water 
  




Incubation buffer 12.1g Tris base 
63.0g Tris HCL 
117g NaCl 
7.4g CaCl2. 2H2O 
Brij 35 0.2% 
Up to 1 litre withMilli-Q 
water 
 
Staining solution 25ml 0.2% C 
Coomassie blue  
25ml 20% HAC 
  
Destaining solution 150ml Methanol 
50ml 100% acetic acid 
300ml Milli-Q water 
  
TE buffer Marligen Biosciences® # 043-
70271FT 
  
50X TAE Buffer 242g Tris 
100ml 0.5M EDTA 
57ml Glacial acetic acid 
Up to 1 litre with Milli-Q 
water 
Biotium Gel Red Nucleic 
acid stain 
Lot # 11G0810  
  
6X loading buffer Fermentas #R0611 
  
4X LDS Sample Buffer Invitrogen NUPAGE® 
#NP0007 
  
ANTIBODIES  Anti - human MMP-2 
antibody 
R&D AF902 
 Monoclonal anti 
goat/sheep IgG 





Anti-MMP-14 antibody  Novus EP1264Y 
  




Anti- β-actin A3854. Sigma-Aldrich, Oslo, 
Norway 
  
Anti- Biotin Cell Signalling Tech ® #7075 
  
IMMUNOSTAINING  
MMP-2 primary antibody  Abcam # ab37150 
  
MMP-14 primary antibody  Novus # NB 110-57216 
  
Secondary antibody  
(Alexa Fluor® 488  Goat 
anti-rabbit) 
Life Technologies® #A11034 
  
ANTIBIOTICS G418 ( Geniticin) #G8168. Sigma-Aldrich, Oslo, 
Norway 
   













GeneCopoeia. Rockville, USA 
GeneCopoeia. Rockville, USA 
 
GeneCopoeia. Rockville, USA 
GeneCopoeia. Rockville, USA 
GeneCopoeia. Rockville, USA 








   
GFP pmax GFP 0049-08 
  
PRIMERS GAPDH (HS_GAPDH_2_SG) 
 
Qiagen # QT01192646 
   





MMP-2 (HS_MMP2_1_SG) Qiagen # QT00088396 
  
MMP-9 (HS_MMP9_1_SG) Qiagen # QT00090040 
  




Fwd: SY 130826294-056 
Rev: SY 130825588-036 
  
           
 
2.2 Cell Culture  
 
2.2.1 Thawing cells from Liquid nitrogen 
Mammalian cells are usually stored in liquid nitrogen for preservation and in order to 
re-passage them, they need to be resuscitated. About 5 ml of the appropriate cell culture 
medium (DMEM-F12 + supplements) was placed in the small cell culture flask (T25), 
after which the cell vials were taken up from liquid nitrogen, quick-thawed by rubbing 
gently. As soon as the cells were thawed, they were quickly re-suspended in the cell 
culture flask, swirled to distribute evenly and incubated in the CO2 incubator for 
attachment. Following attachment, the medium was changed to further dilute the DMSO 




2.2.2 Splitting/passaging of cells 
Cell passaging is done to maintain the cells in their proliferative state otherwise the cell 
culture tends to become too confluent and the cells begin to die due to the exhaustion of 
nutrients. 
Following 80-90% confluency, the cells were split by aspirating the medium, washing 
with pre-warmed PBS and  trypsinized using 1X trypsin- EDTA. The flasks were then 
incubated for 4-8 minutes in the incubator, until the cells detached from the flasks. The 
trypsinization reaction was often stopped by the addition of 4ml medium (for T25 
flasks). The cells were then mixed by pipetting gently, after which the desired volume 
was added into a fresh flask, with fresh medium used to top-up for the appropriate cell 
concentration. The cells were evenly distributed by sliding the flask upwards, 
downwards and sideways, viewed under the microscope to check for their distribution 
and then incubated in the CO2 incubator at 37°C. 
2.2.3 Cryopreservation of Mammalian cells 
Cell cultures were frozen down in order to maintain cells with low passage numbers and 
to limit genetic variations that could be introduced through high passaging rates. 
At about 70-90% confluence, the cells were washed with PBS and gently detached by 
trypsinization and resuspended in the appropriate amount of complete growth medium. 
The cells were then centrifuged after which the supernatant was withdrawn, leaving 
behind the pellets. The pellets were loosened by gently flipping the tube after which the 
cells were resuspended in aseptically prepared and sterile-filtered freezing medium 
(FBS +10% DMSO) to a final concentration of 5 x106 to 1x107 cells per ml 
(approximately 4-6 ml). Aliquots of 1 ml were made into cryogenic tubes after which 
they were placed in insulated vials and gradually frozen for 1 hour at -20ºC, overnight at 




2.2.4 Cell counting:  Naubauer Chamber 
Cell counting is necessary in order to adhere to the required experimental starting cell 
number. 
Cells were grown to confluency after which the media was aspirated, followed by 
washing the cells in PBS and then trypsinization with 1X trypsin EDTA. The 
trypsinization reaction was stopped with 4, 8 or 12ml media, depending on the flask size 
for T25, 75 or 175 respectively 
Approximately 10µl of the cell suspension was introduced into the v-sections of the 
coverslip-naubauer chamber interphase after which the cells were counted under the 
microscope by focusing the counting grid under low magnification objective.  
2.2.5 Cell Harvesting 
Cells are usually harvested for preservation or in order to carry out further analysis. 
Confluent cells were harvested by first aspirating the medium followed by washing the 
cells twice in 1X PBS. The cells were scraped with the appropriate lysis medium, 
incubated on ice for 15 minutes after which they were centrifuged at 9700 rpm for 10 
minutes. The cell supernatant were transferred to fresh tubes and frozen at -70ºC. 
 
2.2.6 Gelatin Column Chromatography 
Gelatin column chromatography is used for the purification of MMPs by using gelatin 
sepharose affinity media (containing immobilized gelatin) due to the high specificity 
with which gelatin binds to the fibronectin-domain in the MMPs.  
The columns were washed /equilibrated 3-4 times with 500µl washing/equilibration 
buffer (0.1 M Hepes pH 7.5, 0.05% Brij) to stabilize the enzyme, after which the samples 
(from cell lysates or cell supernatant) was applied into the column, 100µl at a time. The 
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column was then washed twice with 500µl wash solution with salt (0.1 M Hepes pH 7.5, 
0.05% Brij and 0.5% NaCl) to eliminate unspecific binding, as well as twice with 500µl 
wash buffer (with Brij) to get rid of the salt so it does not get into the eluent. To elute, 
the column was first washed with 30µl of the elution buffer (0.1M Hepes 0.05% Brij and 
0.5% DMSO) and finally eluted into new tubes with about 75µl of the elution buffer. 
 
2.2.7 Measurement of Protein Concentration 
Protein concentration measurement was necessary to ensure that the required amount 
of protein was loaded on gels to make them detectable. It is also of importance as a 
loading control for quantitative analysis. Several techniques are employed in protein 
concentration measurement and in the course of the project, two methods were used 




2.2.7-1 Millipore Direct Detect Method 
Protein concentration measurement by the Millipore Direct Detect spectrophotometer 
provides protein concentration by measuring the intensity of the amide 1 band. The 
amide 1 band is assigned to the C=O stretching vibration which accounts for 80%, and 
about 20% slight contribution by the C-N stretching vibration. 
 
The membrane of the Direct Detect card was loaded with 2µl of each of the cell lysate 
extracts/ conditioned medium as well as the lysis buffer. 
The sample card was then inserted into the Direct Detect machine for the measurement 




2.2.7-2 BioRad DC protein assay 
The BioRad protein assay is a colorimetric assay that determines the concentration of 
proteins through the solubilzation of detergent. Protein concentration is usually 
obtained when the protein interacts with an alkaline copper tartrate solution which in 
turn reduces the fiolin reagent, giving rise to differential colour changes which is mostly 
due to the amino acids tyrosine and tryptophan and to a lesser extent on cysteine, 
cysteine and histidine. The proteins effect colour change by the loss of  1, 2 or 3 oxygen 
atoms hence producing one or more of the reduced species one of  which one the 
characteristic blue colour.  
 
Using a 96-well plate, a standard curve assay was prepared using BSA concentrations of 
0.2mg/ml, 0.4mg/ml, 0.6mg/ml, 0.8mg/ml, 1.0mg/ml, 1.2mg/ml and 1.4mg/ml, for a 
total of  5µl per well. 
5µl of each of the samples was pipetted in duplicates into respective wells after which  
25µl per well working reagent (made up of Reagent A and Reagent S in the ratio of 1:50) 
was added into the standard curve and the sample wells. 
200 µl of Reagent B was added to all the wells, followed by 15 minutes incubation at 
room temperature and reading on the Molecular devices VERSAmax tunable microplate 
reader.  
 
2.3 KILL CURVE 
The kill curve experiment was performed prior to the stable transfection of cells for the 
selection of cell clones. The idea behind it is to incubate cells in different concentrations  
of the antibiotic in question, after which the antibiotic concentration that will yield the 
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least cell population of cells after a period of time, will be used for the selection . When 
this is determined, the same concentration is added to the medium for the stable 
selection of cell clones. Using the same starting cell population, eg approximately 
0.3x106cells per well of a 6-well selective plate, different antibiotic concentrations 
(starting from 0µg/ml for no antibiotic), were added to the respective wells. The volume 
was made up to 2ml (for a 6-well plate) after which the cells were incubated for 
approximately 7 days during which the medium was replaced every 3 days. After about 
7days, the antibody concentration that yielded no cells corresponded to the right 




2.4 MAMMALIAN CELL TRANSFECTION 
Mammalian cell transfection is a process whereby exogenous DNA or RNA is introduced 
in host cell lines. 
2.4.1 Transient Transfection 
Transient Transfection enables for the expression of exogenous DNA or RNA in a host 
cell line for short term purposes, usually between 24 -72 hours. In this case, the nucleic 
acid is not incorporated into the host genome. 
 
On the first day of the experiment, approximately 0.2 x106 cells were seeded in a 6-well 
plate and incubated overnight at 37 ºC. 
For the transfection reactions (in 6 well-plate), the volume of lipofectamine was scaled-
up to 10µl lipofectamine and 90µl optimem, for a total of 100µl. Thus, 10µl of 
Lipofectamine-2000 reagent was diluted in 90µl of optimem reagent per sample (mix 1) 
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and in separate eppendorf tubes, 2.5µg of each plasmid was diluted in optimem, to a 
final volume of 100µl. 
100µl of mix 1 was added to each of mix 2 (for the respective plasmids) and then 
incubated for 5 minutes at room temperature, after which the complex was added to the 
respective wells and incubated for 48 hours at 37º C. GFP was included as a control, to 
check for the transfection efficiency. After about 48hours incubation, the transfection 
efficiency was determined by fluorescent microscopy and then harvested for further 
analysis by western blotting, RT-qPCR etc. 
 
 
2.4.2 Stable Transfection (Mixed clone selection) 
Stable transfection is a ‟long-term”/permanent expression of exogenous DNA into a host 
cell line, with the nucleic acid being incorporated into the host genome.  
 
For the stable transfection, the cells were seeded in T25 flasks on the first day of the 
experiment and then transfected on the second day when they were about 60-70% 
confluent. The transfection was performed in the same way as the transient transfection, 
however, the experimental conditions such as the plasmid amount, lipofectamine and 
optimem were stepped up according to the protocol. For the T25 flask, the plasmid 
amount was increased to 6.25µg. Again, the medium was changed every third day post-
transfecton with medium containing the appropriate concentration of antibiotic for the 
selection. Following confluency, the cells were trypsinized and seeded in a T75 flask, for 




2.5 REAL TIME QUANTITATIVE POLYMERASE CHAIN REACTION (RT-qPCR) 
Real time PCR is used in the amplification of template DNA into multiple copies of 
(thousands or even millions) using a thermostable polymerase. The polymerase allows 
the extension of short single-stranded synthetic oligonucleotides (primers) during 
repeated cycles (20-40) of denaturation, primer annealing and primer extension in 
which the thermostable polymerase incorporates synthetic deoxyribonucleotides to 
duplicate the segments between the primers. These steps are temperature dependent 
and are carried out in the thermocycler. PCR is usually exponential initially and then 
plateaus (at different rates) when a reagent is limiting. At the exponential phase, the 
target amount doubles at every cycle (under normal condition) and the CT (cycle 
number) value is taken, corresponding to when the signal is above the background. The 
resulting CT are eventually resolved to determine the relative gene expression. 
 2.5.1 RNA Purification and measurement 
Cells were seeded in 6 well-plate and at about 80-90% confluence, total cell lysate was 
made by first washing the cells 3X with PBS and then lysing the cells with lysis buffer 
containing 350µl buffer RLT (Qiagen®) and 6µl 3M DTT. The lysates were then scraped 
into eppendorf tubes and stored at -70ºC (if not using immediately). 
Total RNA was purified from the cell lysates using the Qiagen RNeasy Mini kit, following 
the protocol as follows: 
1. The lysates were pipetted into the QIAshredder spin column on a 2ml tube and 
centrifuged for 2 mins at maximum speed. 
2. The homogenized lysates were transferred to a gDNA Eliminator column placed 
on new 2ml collection tubes  followed by 30 second centrifugation at 10,000 rpm 
3. The column from above was discarded and to the flow-through was added 350µl 
of 70% ethanol followed by gentle pipetting to mix 
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4. 700 µl of the above mix was then transferred to RNeasy spin column on 2ml 
collection tube and centrifuged for 30 seconds at 10,000 rpm. The flow-through 
was discarded while the collection tube was retained. 
5. 700µl of buffer RW1 was added to the column and then centrifuged for 30 
seconds at 10,000 rpm. 
6. The flow-through from above was discarded while the column was reused. 500µl 
of buffer RPE was added to the column followed by 2 minutes centrifugation at 
10,000 rpm 
7. The tube with the flow-through was discarded while the column was placed on a 
new 2ml collection tube and centrifuged for 1 minute at maximum speed. 
8. The RNeasy column was then placed on a new collection tube after which 40 µl of 
RNase–free water was added to the column, followed by a 1 minute 
centrifugation at 10,000 rpm to elute the RNA and kept on ice. 
9. The concentration of the purified RNA was measured on the Nanodrop after 
which the samples were stored at -70°C. 
 
2.5.2 The Nanodrop Technique 
The Nanodrop technique involves the measurement of nucleic acid concentration in 
microliter volumes, using the Nanodrop spectrophotometer. It is a fast and easy method 
that simply requires the placement of sample directly on top of the detection surface and 
using surface tension to create a column between the ends of the optical fibres and 
forming the optical path. Its operational spectral range is between 220-770 nm with a 
sensitivity range of between 2 and 3700 ng/µl; and the total time utilized per sample 




Log in to the computer connected to the Nanodrop machine 
Open the ND-1000 program 
Select Nucleic acid – OK 
Clean the Nanodrop sensor twice with 2 µl RNase-free water 
Select RNA-40  
Pipette 2 µl RNase-free water and click BLANK 
Clean off the water with lens paper 
Pipette 2 µl sample 
Click on measure 
Click on PRINT SCREEN 
Clean with lens paper in-between samples 
Click on PRINT REPORT 
When done, clean off the last sample with lens paper, clean the sensor with 2 µl RNase-
free water and secure the sensor with clean lens paper. 
 
2.5.3 cDNA synthesis 
cDNA synthesis is used to reverse transcribe template RNA into DNA copies. 
The purified RNA sample was prepared for cDNA synthesis by standardizing it to 
12ng/µl (according to the protocol). The sample was then made up to 12 µl by adding 
the appropriate volume of RNA-free water and kept on ice. 
Master-mix 1 was prepared using 2µl per sample of gDNA wipeout and 2µl per sample 
RNase-free water. 4 µl of the mix was added to PCR tubes while 10 µl of the diluted RNA 
sample was added to the tubes on the RNA bench, in order to prevent RNA 




42°C for 2 minutes 
4°C for 2 minutes 
4°C for ∞  
While the first PCR was running, Master-mix 2 was prepared using 1µl per sample 
RTenzyme, 4 µl per sample buffer and 1 µl per sample primer mix. 6 µl of the mix was 
then added to the PCR 1 product and PCR 2 was run at: 
42°C for 15 minutes 
95°C for 3 minutes  
4°C for 7 minutes 
4°C at ∞ 
The cDNA derived was measured on the Nanodrop and stored at -20ºC. 
 
2.5.4  Polymerase Chain Reaction (SybrGreen Assay) 
Sybr® Green is a double-stranded DNA intercalating dye that emits fluorescence when 
bound to DNA. It is the most commonly used dye for non-specific detection, requiring a 
pair of specific primers to amplify the target. The dye emits at 520 nm and the emitted 
fluorescence is detected and related to the amount of the target. 
 
Master Mix 1 for the PCR was made with 12.5 µl Sybr green and 10.5 µl per sample 
Master Mix 2 was also made for each of the primers for the PCR reaction (eg GAPDH, β-
actin, MMP-2, MMP-9 etc), using 1 µl primer per sample + 23 µl Master Mix. 
 24 µl of the Master-Mix 2 was pipetted into the corresponding test wells, to which 1µl of 
the respective cDNAs were added.  
The no-template control contains only water and the reaction mix. It is used for the 
detection of contaminations, non-specific amplifications or primer dimers. Here, 1µl 
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RNase-free water was added to the wells containing Master-Mix 2 (SybrGreen, water 
and the respective primers).  
The PCR was run on the Stratagene® MX3000 according to the protocol, using ROX as 
the dye. 
 
2.6 WESTERN BLOTTING 
Western blotting is a protein detection and analysis technique used for the separation of 
proteins according to their sizes, based on the ability of the proteins to bind to specific 
antibodies. 
2.6.1 Sample Preparation (Cell lysates) 
Approximately 0.3 - 0.6 x 106 cells were grown to confluency after which they were 
washed three times with PBS and then harvested with 100µl lysis buffer made up of 50 
µl 4X LDS sample buffer, 30 µl milliQ water and 20 µl 0.1M DTT.  
The cell lysates were stored at -20ºC when not using immediately. 
For the western blot, the cell lysates were first sonicated at 15 cycles: 15 seconds ON 
and 15 seconds OFF, using the Bioruptor® plus diagenode machine. Samples were 
sonicated to disrupt their membranes and release their contents  after which 30 µl 
samples were transferred to new eppendorf tubes after which and heated for 3 minutes 
at 85ºC. The samples were then loaded onto the gel ( nuPAGE 1.5mm 4-12% Bis- Tris 
gel) and the nuPAGE gel electrophoresis was run  for 35 minutes in 1x NuPAGE  Running 
buffer (MES SDS) using the Invitrogen Lite technologies Power Ease 500 machine.  
 
2.6.2 Blotting 
After the gel run, blotting was done by first preparing the PVDF membrane (7.5cm by 
8.5cm), which is the same size orientation as the gel. The PVDF membrane was soaked 
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for 3 seconds in methanol, 10 seconds in water and >5 minutes in blotting buffer. Two 
filters were also soaked in the blotting buffer. When the gels were done running, the 
cassette was broken using a gel knife and with the gel on the larger plate, the wells were 
removed. The pre-wetted filter was placed on the gel and turned (filter-down) on the 
work-bench after which the lowest part of the gel was removed. Pre-treated PVDF 
membrane was then placed on the gel, followed by the second pre-wetted filter. Air-
bubbles were then removed by rolling out with a glass rod. Three pre-wetted pads were 
placed in the blotting module, followed by the “gel-in-PVDF and filter” set-up and finally 
the last three pre-wetted pads. The blotting module was placed in the cathode core after 
which the inner chamber was filled with blotting buffer and the outer chamber, with 
water for cooling. The Blot was run for protein transfer according to the protocol). 
 
2.6.3 Detection 
Following the blotting, the membrane was washed for 5minutes in 5ml TBST, blocked 
for 1 hour at room temperature (with rotation) and incubated overnight (with rotation) 
at 4ºC in primary antibody diluted appropriately in blocking buffer. The membrane was 
then washed with 5ml TBST for 3x5 minutes to remove the primary antibody and then 
incubated for 1 hour at room temperature with secondary antibody diluted 
appropriately in blocking buffer. After the secondary antibody incubation, the 
membrane was washed 3x 5 minutes in 5ml TBST, incubated for 1 minute in 1.5ml 
Luminol reagent using 1:1 ratio of solution A to solution B. The membrane was then 
sealed in a plastic wrap and exposed using the LEICA-3000® machine. 
 
For Western blotting on cell supernatant, after 24 hours incubation, the medium from 
the cells was replaced with serum-free medium, after washing first with PBS. The cells 
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were incubated for 48hours, after which the medium was harvested and centrifuged for 
10 minutes at 1600 rpm. Prior to storage at -70ºC, 10% freezing solution (1M Hepes 
solution pH7.4 and 0.1M CaCl2) was added to the cell supernatant. The western blotting 
procedure for the conditioned medium was exactly the same as that of the cell lysates 
except for the omission of the sonication step, which is not necessary for cell 
supernatant.  
 
2.7 GELATIN ZYMOGRAPHY 
Gelatin Zymography is a method used in the detection of proteolytic enzymes that are 
able to degrade gelatin from various biological sources such as cell culture, cell 
conditioned medium,  bodily fluids and tissue samples. 
2.7.1 Conditioned Medium  
Conditioned medium for zymography was generated in exactly the same way as that of 
the Western blotting. 
2.7.2 SDS-PAGE  
The samples were analysed by gelatin zymography in 7.5% separating gelatin gel and 
4% stacking gel.  
The separating gel was cast and left to polymerise for approximately 20 minutes after 
which it was topped with the stacking gel. The comb was inserted at this point and 
following polymerisation, the samples (7.5μl +1X loading buffer) were loaded onto the 
gel and run using the Pharmacia Biotech Electrophresis Power Supply (EPS 600) at a 
constant current of 18A ( for 1 gel) and 36A (for 2 gels) for approximately 2 hours, in 1X 
electrophoresis buffer . 
The gel was then washed for 2x30 minutes in washing buffer after which it was 
incubated overnight in incubation buffer  
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Following the overnight incubation, the gel was stained for 1 hour in 50ml staining 
solution and then destained in 50ml destaining solution for 1 hour, after which it was 
viewed under white light. 
Gel photography was done using the UVP BioDocit ™ machine at 0-0-80 intensities 
 
2.8 BACTERIAL TRANSFORMATION AND PLASMID PURIFICATION 
Bacterial transformation is one the methods by which plasmids are introduced in 
competent bacterial cell, which in turn enables the amplification of the plasmid into 
multiple copies. 
 
The plasmids used for the project were expanded by the transformation of the E.coli 
DH5α competent bacteria. The plasmids were purified using the Qiagen  Miniprep kit 
and the Macherey Nagel Nucleobond® Xtra Midi plasmid purification kit respectively. 
 
The transformation of the E. coli DH5-α competent bacteria was done by gently thawing 
50-100µl of the bacteria on ice after which approximately 1-2µl of the plasmid was 
added to the bacteria, tapped gently to mix and incubated on ice for 30 minutes. 
Following the incubation, the bacteria was heat-shocked by incubating for 42 seconds at 
42ºC and then returned to ice for 2 minutes. 300µl of pre-warmed SOC medium was 
added to the bacteria, which was then incubated with shaking at 37ºC and 182rpm for 
16-18 hours. 
 
2.8.1 Miniprep plasmid purification:  
Following bacterial transformation, one colony of the transformant was inoculated into 
5ml of prewarmed LB medium (100µg/ml ampicillin) and incubated overnight with 
48 
 
shaking at 37ºC. Approximately 1ml freeze stock of the plasmid was made by adding 
20% glycerol and freezing at -70ºC.  
The rest of the bacterial culture was then purified using the Qiagen miniprep plasmid 
purification kit as follows: 
 
The culture was centrifuged at 8000 rpm, the supernatant was discarded while the 
pellets were resuspended in 250µl of Buffer P1.The tube was tapped gently to mix and 
the resuspended cells were transferred to new eppendorf tubes 
250µl of buffer P2 was added, followed by the inversion of the tube 4-6 times to achieve 
proper mixing after which the mix was incubated for 5 minutes at room temperature. 
350µl of Buffer N3 was added to the mix followed by gentle mixing (inversion of the 
tube 4-6 times) and centrifugation at 13,000rpm for 10 minutes. 
The supernatant was then applied to the spin column and centrifuged at 3,000rpm for 
60 seconds after which the flow-through was discarded  
The column was washed with 750µl of Buffer PE and centrifuged for 60 seconds. 
The column was left to dry at room temperature for 10 minutes after which the 
collection tube was replaced. 
50µl of the elution buffer was then added to the column, left to stand for 1 minute and 
then followed by 1 minute centrifugation at 12,000rpm to elute the DNA. 
The concentration of the purified plasmid DNA was measured using the Nanodrop and 
the plasmid was stored at -20ºC. 
 
2.8.2 Midiprep Plasmid purification 
Following bacterial transformation, one colony of the transformant was inoculated in 
100ml of prewarmed LB medium (100µg/ml ampicillin) and incubated overnight with 
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shaking at 37ºC. Approximately 1ml freeze stock of the plasmid was made by adding 
20% glycerol and freezing at -70ºC. 
The rest of the culture was centrifuged at 5000 x g for 10 minutes, at 4°C after which the 
supernatant was discarded and the plasmid purified using the Nucleobond® plasmid 
purification kit according to the protocol below: 
 
1. The pellet was resuspended in 8ml resuspension buffer RES (plus added RNase). 
8ml of the lysis buffer, LYS was added to the suspension and mixing was done by 
inverting the tube 5 times, followed by a 5 minute room temperature incubation 
to lyse the cells. 
2. During the incubation period, the nucleobond® column as well as the inserted 
column, was equilibrated by applying 12ml of the equilibration buffer EQU 
around the rim of the filter. 
3. Following the 5 minute incubation period, 8ml of the neutralization buffer, NEU 
was then added to the cell lysate which was gently mixed by inverting the tube 15 
times. 
4. The lysate was then gradually clarified (by inverting the tube 3 times) and loaded 
onto the column in the same manner as the equilibration buffer EQU was applied 
(around the rim of the filter). 
5. The column filter was then washed with 5ml equilibration buffer after which the 
filter was discarded and the column was washed with 8ml wash buffer, WASH. 
6.  Following the washing, the plasmid DNA was eluted by directly adding 5ml 
elution buffer, ELU. 
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7. 3.5ml room-temperature isopropanol was then used to precipitate the eluted 
plasmid DNA after which it was vortexed properly and incubated for 2 minutes at 
room temperature, followed by centrifugation at 12,500 x g for 30 minutes at 4°C. 
8. The supernatant was carefully discarded while the pellet was washed with 2ml 
70% ethanol and centrifuged at 12,500 rpm at room temperature for 5 minutes. 
9. Following the last centrifugation, the supernatant was discarded carefully and 
the pellets were dried at room temperature for 15 minutes after which the DNA 
pellet was dissolved in 500μl TE buffer. The DNA concentration was measured on 
the Nanodrop after which the DNA solution was stored at -20°C for later usage.  
 
2.9 RESTRICTION ENZYME DIGESTION AND AGAROSE GEL ELECTROPHORESIS  
Restriction enzyme digestion is the use of restriction endonucleases to break the sugar-
phosphate backbone of bacterial DNA at specific nucleotide sequences known as the 
restriction sites, in order to generate smaller fragments. 
 
Agarose gel electrophoresis is used in the analysis of DNA fragments that have been 
generated by restriction enzyme digestion, according to their molecular sizes which 
range from between 500 to 30,000 base pairs.  
 
Plasmid Digestion: 
The restriction enzyme digestion was performed by combining the following in a 1.5ml 
reaction tube: 
1µg plasmid 
1µl restriction enzyme (Nde1 R0111S Lot 0280805) 
2.8µl 10X Buffer (NEB Buffer 2 B 70025 Lot 1205 A) 
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Distilled water (for a total volume of 25 µl of the reaction mix) 
 
Overnight Incubation at 37°C 
 
2.9.1 Gel preparation: 
1% agarose gel was prepared by mixing 1g agarose gel powder in 100ml 1X TAE buffer, 
which was dissolved by heating in the microwave. The gel was poured up to about 0.5cm 
in a gel plate and left to polymerise for bout 20-25 minutes after comb insertion. 
 
Both the digested and undigested samples were prepared with 6X loading dye ( 
Fermentas® #R0611 Lot 00000802) 
 
The “set” gel was transferred to the electrophoresis chamber after which 1XTAEbuffer 
was used to cover the gel. The samples, both digested (for test) and undigested (for 
control) as well as the 100bp (Fermentas GeneRuler™ 100bp DNA Ladder plus # SM 0321 
Lot 00016171) and 1kb molecular weight standards (Fermentas Ladder Gene Ruler™ 
1kb DNA ladder plus #SM1331 l Lot 00000201) were loaded on the gel in the correct 
order. The gel was run for 1hour at a constant voltage of 90V. 
 
2.9.2 Staining and Development 
The gel was stained in 20% staining solution (Biotrun Gel Red Nucleic acid stain Lot 
11G0810) for 30 minutes with slight shaking after which it was washed slightly in water 




2.10 DNA SEQUENCING 
DNA sequencing is a process used in the determination of the order of nucleotide 
sequences along a DNA strand. 
 
The sequencing reaction was carried out by making mixes of the following, for the 
forward and reverse primers respectively:  
1-3 ng 5X Sequencing buffer 
3-10 ng Big Dye 3.1 
5-20 ng DNA template 
10-40 ng forward and reverse primers respectively 
The mix was made up to 20µl with nuclease-free water 
The sequencing PCR was run using the program: 
 30 cycles 
96°C - 10 secs 
50°C - 10 secs 
60°C - minutes 
4°C - infinity 
 
The sequencing PCR product was eventually delivered to the sequencing platform for 
further analysis after which a nucleotide BLAST search was done on PUBMED. 
 
2.11 IMMUNOSTAINING AND CONFOCAL MICROSCOPY 
Immunostaining and confocal microscopy is used in the detection of an antigen in cell or 
tissue sections by means of antigen-antibody recognition. Confocal microscopy is 




10,000 cells were seeded in the 8-well chambered glass slide up to a total medium 
volume of 200µl and incubated overnight at 37°C. 
After the overnight incubation, the medium was aspirated after which the cells were 
fixed using 8% ice-cold PFA in PBS and incubated on ice for 10 minutes. 
The cells were then washed twice with 1X PBS and permeabilized  by adding 200µl 0.1% 
Triton x100, followed by a 5 minute incubation at room temperature. 
Blocking was done by first washing the fixed cells twice with 1X PBS and incubating in 
3% goat serum in PBS for 30 minutes at room temperature after which the blocking 
solution was aspirated and the cells incubated in 200 µl primary antibody in 1% goat 
serum in 1X PBS for 1 hour at room temperature. 
The primary antibody was aspirated after the 1 hour incubation and the cells were 
washed 6 times with 1X PBS after which they were further incubated  with 200µl 1:200 
secondary antibody in 1% goat serum in 1X PBS for 30 minutes at room temperature. 
The cells were then finally washed 6 times with 1XPBS and analysed using confocal 
microscopy. 
 
2.12 IN SITU ZYMOGRAPHY 
 
In situ zymography is a technique that aids in the detection of enzymatic activity in cell 
culture or tissue sections. Detection by this method occurs when a substrate is deposited 
and incubated on or under cells or tissue and the nature of the substrate used will 
determine the actual enzyme that will be detected. 
 
Gel preparation:  
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2% sucrose and 2% gelatin (porcine) gel was prepared by weighing 0.2g gelatin and 
0.2g sucrose, to which were added 1x sterile PBS up to 10 ml. The mixture was heated in 
56-62°C water bath till the solution became homogenized after which it was sterile-
filtered using a 0.2µm filter and then left to cool down slightly. 
 
The DQ gelatin was prepared by adding 1ml sterile water to 1mg DQ-gelatin powder and 
mixed properly.  
A 1ml working solution containing 25µg/ml DQ-gelatin was then prepared using 975µl 
filtered 2% gelatin and 2% sucrose solution + 25µl DQ-gelatin (1mg/ml) out of which 
100µl was pipetted into each of the chambered glass slide wells. 
The chambered glass slide was then incubated for 10 minutes at 4°C and following 
polymerization, about 100,000cells in 100µl serum-free medium was added per well. 
The glass slide was incubated for about 10 minutes after which the cells were visualized 
under the confocal microscope for gelatinolytic activity which is seen as green 
fluorescence. 
 
2.13 xCELLigence System 
The xCELLigence system uses the principle of microelectronic cellular impedance 
technology to monitor the behaviour of cells such as adhesion, proliferation, migration 
and cytotoxicity in real time. 
 
2.13.1 Cell adherence and proliferation 
For the adherence and proliferation assay, 50µl of the complete growth medium was 
pipetted into each of the wells of the E-16 plate after which the plate was equilibrated by 
incubating for 1 hour at 37°C.  
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Following the 1 hour incubation, a background measurement was done using the step 1 
of the xCELLigence RTCA SW. 
The cells were then washed, trypsinized and counted, out of which the required amount 
of cells in a total of 100µl was added per well. The plate was incubated under the hood 
for 15-20 minutes after which it was placed in the DP system for measurement at 5 
minutes interval for 12 hours and 15 minutes interval for 72 hours. 
 
2.13.2 Cell migration 
160µl of complete growth medium was added to each of the BC (bottom chamber) wells 
of the CIM-16 plate after which the BC and the TC (top chamber) were assembled in the 
proper orientation. 30µl of SFM was then added to the TC wells after which the 
assembled CIM plate (with medium) was incubated for 1 hour at 37°C followed by 
background measurement using step 1 of the xCELLigence RTCA SW. 
The cells were washed with PBS and trypsinized with trypsin-EDTA. Trypsinization was 
stopped with a few milliliters of media containing serum after which they were 
centrifuged at approximately 800g for 5 minutes.The pellets were washed by 
resuspension in SFM and centrifuging a second time for 5 minutes at 800g. Following 
the washing, the cells were again resuspended in SFM after which they were counted 
and 100µl of the cell suspension containing the appropriate cell number added to each 
of the TC wells of the CIM plate. 
The plate was incubated under the hood for 15-20 minutes after which it was placed in 






2.13.3 Cell invasion 
Matrigel was defrosted on ice and diluted (1:3) in SFM for a total of 800µl out of which 
50µl was added to each of the TC wells of the CIM-16 plate (sitting on the BC for 
support) using cool pipette tips always. 30µl of the matrigel was taken out, leaving the 
remaining 20µl to coat the wells. The plate was incubated for 10 minutes at 37°C after 
which 160µl medium with FBS was added to the BC wells. The TC and BC were then 
assembled in the proper orientation followed by the addition of 25µl SFM to cover the 
matrigel in the TC, after which the plate was incubated at 37°C for 1 hour. The 
background was measured using step 1 of the xCELLigence RTCA SW after which cells in 
100µl SFM were added to the TC wells. The CIM plate with cells was incubated in the 
hood for 15-20 minutes, to allow the cells settle, after which it was placed in the DP 








The results that are presented in this thesis have been divided into 3 main sections:  
MMP-2 overexpression, MMP-14 knockdown, and the analysis of the effects of the 
overexpression and the knockdown on the cells. 
  
3.1 Determination of MMP-2 expression levels in wild-type HSC-3 cells 
 
Going by the hypothesis that MMP-2 could also have some intracellular  
 
function, an overexpression of the intracellular isoform of the protein was important to 
help investigate these functions especially in terms of cell migration and invasion. Using 
the HSC-3 cells, there was the need to ensure that they were not endogenously 
expressing the protein and thus Western blotting was employed to ascertain the 
expression level of the MMP-2 protein in HSC-3 cell lysates ( Fig. 7) 
 




Figure 7. HSC-3 cells do not endogenously express MMP-2 protein. 
Western Blot analysis for MMP-2 expression on HSC-3 wild-type cell lysates was performed by 
seeding 1.0x 106  cells of the cells which was harvested at confluence using 100μl lysis buffer and 
run on 4-12% bis-tris gel. 
Lane 1: molecular weight standard ( Magic Marker); lane 2: positive control (conditioned 
fibroblast medium; lane 3: 30 μl HSC-3 cell lysate (-DTT); lane 4: 30 μl HSC-3 cell lysate 
(+DTT).The proteins were resolved by SDS-PAGE, transferred to a nitrocellulose membrane and 
detected by ECL using the  Goat anti-human-MMP-2 primary antibody (AF902 R&D) (1:500) and 
the HRP-conjugated anti-goat/sheep secondary antibody (A9452 Sigma-Aldrich) (1:100,000). 
 
 
As shown in figure 7, MMP-2 protein with the expected molecular weight of 72kDa was 
identified in the positive control sample ( lane 2), while no MMP-2 could be detected in 
the HSC-3 samples (lanes 3 and 4). As a result of the finding, the cells were deemed very 
suitable for the proposed protein overexpression studies with the MMP-2 plasmid. 
 
 
3.2 MMP-2ic overexpression in HSC-3 cells 
Since HSC-3 cells do not express any endogenous the MMP-2 protein, they were 
transfected with the plasmid, Ex-Z5731-m02-MMP-2 (GeneCopoeia), which contain an 
insert of transcript variant 2 of MMP-2. This variant encodes a protein which lacks the 
first 54 amino acids of MMP-2 (named MMP-2ic), hence it lacks the signal peptide and 
parts of the prodomain and is therefore cytoplasmic and possibly active. Another 
plasmid, Ex-neg-M02 (GeneCopoeia), lacking the MMP-2 insert served as an empty 
vector control for the overexpression. Prior to the overexpression, the plasmids were 
transformed into the E.coli DH5-α  bacteria for expansion, followed by purification with 
the Qiagen® Miniprep plasmid purification kit ( and subsequently with the Nucleobond® 
Xtra Midiprep). In order to confirm the identity, the purified plasmids were subjected to 





                             
Figure 8: Nde 1 restriction enzyme digestion of Ex-Z5731-M02-MMP-2 and Ex-neg-M02 
Plasmids. 
Agarose gel electrophoresis for the verification of cDNA encoding intracellular MMP-2 ((Ex-
Z5731-M02-MMP-2) and  Empty vector (Ex-neg-M02). 6.3µg of the purified plasmids were 
digested with 20U of the Nde1 restriction enzyme. The samples were prepared by adding 6X 
loading buffer (Fermentas) to 10µl of the sample, after which they were run on 1% agarose gel. 
Lane 1: Undigested MMP-2 plasmid (U1); lane 2: digested MMP-2 plasmid (D1); lane 3: 
Undigested empty vector plasmid (U2), land 4: digested empty vector plasmid (D2); lane 5: 1 kb 
molecular weight standard (NEB); lane 6: 100bp DNA ladder (Fermentas GeneRuler™). Gel 
staining was done with GelRed nucleic acid stain (Biotium) followed by imaging on the BioRad 
Gel Doc™ 2000. 
 
Figure 8 shows the presence of one main band of about 7656bp for the undigested 
MMP-2 plasmid (lane 1), two bands for the digested MMP-2 plasmid with sizes 2590bp 
and 5066bp (lane 2); one main band for undigested empty vector plasmid with a size of 
5798bp (lane 3) and 2 bands for the digested empty vector plasmid with sizes 732bp 
and 5066bp (lane 4) on 1% agarose gel. The detected bands for the digested plasmids 
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corresponded to the calculated fragment sizes that would be generated by the Nde1 
restriction enzyme, as deduced from the plasmid map.  
 
The above result notwithstanding, the purified MMP-2 plasmid DNA was sequenced for 
further confirmation of the plasmid identity. DNA sequencing was done on two 
individually purified MMP-2 plasmids using both forward (5’- CAGCCTCCGGACTCTAGC-
3’) and reverse (5’- TAATACGACTCACTATAGGG-3’) primers for the forward and 




Figure 1 in the appendix shows the nucleic acid sequences generated from the purified 
plasmid. A nucleic acid BLAST search on NCBI revealed about 98% complementarity 
between the sequences of the MMP-2ic insert and the human MMP-2 transcript variant 
2 (Accession number NM 001127891) found in the database. 
 
3.3 Confirmation of Intracellular MMP-2 (MMP-2ic) overexpression in HSC-3 cells 
Single cell clones generated by the overexpression of the intracellular MMP-2, were 
provided for this work (12 HSC-3-MMP-2ic clones and 2 HSC-3-EV clones), and in order 
to proceed with the proposed study, the clones were analysed for the overexpression of 




Figure 9: Conditioned cell medium from HSC-3 cells overexpressing MMP-2ic degraded 
gelatin. Conditioned media from 12 stably selected HSC-3-MMP-2ic clones and 2 for empty 
vector clones were prepared with 5X loading buffer and run on the SDS-PAGE for enzymatic 
activity. 
Lane 1: Positive control for human pro-MMP-9, active MMP-9, pro-MMP-2 and active MMP-2; 
lanes 2-13: 7.5µl HSC-3 conditioned medium for the HSC-3-MMP-2ic clones respectively; lanes 
14 & 15: 7.5µl HSC-3 conditioned medium for the empty vector clones respectively. Gel staining 
was done with Coomassie blue containing 20% acetic acid and gelatinolytic activity was seen as 
clear bands on a blue background.  
 
Figure 9 shows  bands with an apparent size similar to pro-MMP-2 with varying degrees 
of gelatinolytic activity (lanes 2-13). No bands with the size corresponding to MMP-2 
were observed for the empty vector clones (lanes 14 and 15). In all samples, a band 
corresponding to pro-MMP-9 could be observed on the zymogram. That 
notwithstanding, there were no observed bands for either active MMP-2 or MMP-9 on 
any of the samples. 
As a further confirmatory test for MMP-2ic overexpression, an RT-qPCR was run on total 
RNA from the cell clones. RNA was extracted from the cell lysates using the Qiagen 
RNeasy kit. Purified RNA of ≥ 100ng/μl were sent out to the integrity testing platform, to 




Figure 10: Intact RNA were isolated from most of the HSC-3-MMP-2ic and HSC-3-EV single 
cell clones 
Gel electrophoresis using the Bioanalyzer showing the integrity of RNA after purification. The 
RNAs with measured concentrations of  >100ng/µl were tested for integrity at the platform 
using the Experion RNA StdSens. 
Lane 1: Molecular weight standard ( Experion StdSens); lanes 2-9: RNA from stable MMP-2 
clones 1, 2, 4, 5, 7, 9, 10 and 12; lanes 10 and 11: RNA from stable empty vector clones; lanes 12 
and 13: RNA from transient transfection with PmaxGFP  and MMP-2ic respectively. 
 
Figure 10 shows that integrity testing yielded intact RNA bands corresponding to the 
28S and 18S ribosomal RNA (lanes 2-6 and 9-13) as well as some degraded RNA (lanes 7 
and 8). The samples with degraded RNA were excluded from further analysis by RT-
qPCR. 
An RT-qPCR was run on the intact RNA samples using SybrGreen assay, with  Gapdh and 
β-actin serving as the  reference genes. The CT  values derived from the RT-qPCR were 
normalized to the internal controls after which the fold change was determined by 




              
Figure 11: Stable transfection of HSC-3 cells with Ex-Z5731-M02-MMP-2 resulted in an 
increase in the MMP-2ic gene expression.  
RT-qPCR result shows the relative expression of MMP-2ic in HSC-3 cell clones using SybrGreen 
dye assay. Gapdh and β-actin were used as the reference genes. Lanes 1&2: HSC-3-EV clones; 
lanes 3-10: HSC-3-MMP-2ic clones 1, 2, 4, 5, 7, 9, 10 and 12. 
 
 
Figure 11 shows the increase in fold of MMP-2ic expression in HSC-3 cell clones relative 
to the empty vector control (EV-7), when the expression level of the empty vector was 
set at 1. The MMP-2ic mRNA expression levels were highest in HSC-3-MMP-2-2ic and 
lowest in HSC-3-MMP-2-7ic. The RT-qPCR results correlate with the results from the 
zymography, in which the strongest band was observed in HSC-3-MMP-2-2ic and the 




3.4 MMP-14 Knockdown 
In order to effectively determine the role of MMP-14 in HSC-3 cell migration and 
invasion, it was of paramount importance to determine first if the protein was 
endogenously expressed in HSC-3 cells. To ascertain this, Western blot analysis was 




                                    
Figure 12: HSC-3 cells endogenously express MMP-14. 
Western Blot analysis for MMP-14 expression in wild-type HSC-3 cell lysates was carried out by 
seeding 1 x 106 cells which were harvested at confluence with100μl lysis buffer and run on 4-
12% Bis-Tris gel. 
Lane 1: molecular weight standard (Magic Marker); lane 2: 30 μl HSC-3 cell lysate (-DTT); lane 3: 
30 μl HSC-3 cell lysate (+DTT). 
The proteins were resolved by SDS-PAGE, transferred to a nitrocellulose membrane and 
detected by ECL  using Rabbit anti-human MMP-14 primary antibody (Novus EP1264Y) 




Figure 12 shows that MMP-14 protein with the expected molecular weight of 
approximately 66kDa was detected in the HSC-3 samples, both in the presence and 
absence of DTT.  
 
3.4.1 Transient transfection using shRNAs for MMP-14 
To study the role of MMP-14 protein in HSC-3 cell, an shRNA strategy was chosen for 
knockdown of MMP-14. In order to determine which shRNA construct that would give 
the most efficient knockdown, 4 different shRNA construcs were tested by transient 
transfection of the HSC-3 cells (Figure 13).  
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Figure 13A: MMP-14 protein expression was reduced by MMP-14 shRNAs.  
Western blot analysis was carried out on HSC-3 cell lysates after 0.3 x 106 HSC-3 cells were 
transfected on a 6-well plate using 2.5µg shRNA plasmid DNA. 
The cells were harvested 48 hours post-transfection using 300 μl RIPA buffer (+ protease 
inhibitor) after which equal concentrations (20 µg) of the sample was prepared with sample 
buffer and  loaded on 4-12% bis-tris gel. 
Lane 1: molecular weight standard (Magic Marker); lanes 2-5: lysates of shRNAs 1-4 
transfectants respectively; lane 6: lysate of HSC-3 transfected with pmaxGFP; HSC-3 cell lysates ( 
GFP); lane 7: lysate of HSC-3transfected with scrambled control; lane8: wild-type HSC-3 cell; 
lysates; lane 9: biotin ladder. 
The proteins were resolved by SDS-PAGE, transferred to a nitrocellulose membrane and 
detected by ECL  using Rabbit anti-human MMP-14 primary antibody (Novus EP1264Y) 
(1:2000) and Goat anti-rabbit IgG H+L chain specific secondary antibody (Southern Biotech) 
(1:2000). 
Figure 13B: As a loading control, the blot was reprobed with anti-β-actin (Sigma) (1:1000). 
 
 
Figure 13 shows that MMP-14 shRNA constructs 1 and 2 gave the most knockdown in 
HSC-3 cells (lanes 2 and 3). The extra bands in the HSC-3 wild-type denotes some level 
of degradation of the protein (lane 9). Probing with anti-β-actin antibody revealed bands 
of approximately 42kDa, which correpond well with the expected size of human β-actin. 
 
3.4.2 Stable transfection of shRNA for MMP-14 
Based on the above result, the MMP-14 shRNA constructs 1 and 2 were further used to 
stably transfect HSC-3 cells for  MMP-14 knockdown using puromycin as the stable 
selection marker. In this case, bulk transfections were done for the selection of mixed 
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clones. The knockdown was verified by Western blotting (Figure 14) and RT-qPCR 
(Figure 15).  
            
Figure 14A: Stable transfection of HSC-3 cells with shRNA1 and shRNA2 resulted in a 
detectable knockdown of MMP-14 in cells transfected with shRNA2 only 
 
Bulk transfectants generated from the stable transfection of HSC-3 cells with shRNA constructs 1 
and 2 (HSH011268-(1-2)-nU6) and a scrambled control (CSHCTR001-nu6) were analysed by 
loading equal amounts of the protein (+sample buffer) on 4-12% Bis-Tris gel.  
Lane 1: molecular weight marker (Magic Marker); lanes 2: 30µl HSC-3 cell lysates (shRNA 1); 
lane 3: 30 µl HSC-3 cell lysate (shRNA 2); lane 4: HSC-3 cell lysates (scrambled control); lane 5: 
30µl HSC-3 cell lysates (wild-type); lane 6: sample buffer; lane 7: biotin ladder. 
The proteins were resolved by SDS-PAGE, transferred on nitrocellulose membrane and probed 
with Rabbit anti-human MMP-14 primary antibody (Novus EP1264Y) (1:2000) and Goat anti-
rabbit secondary antibody (Southern Biotech)(1:2000). 
Figure 14B:A reprobe for loading control was carried out using anti-β-actin (A3854 Sigma) 
(1:1000). 
 
Figure 14A shows that only MMP-14 shRNA construct 2 was able to knockdown MMP-
14 expression in HSC-3 cells after stable transfection. This is seen in the fainter band 
corresponding to approximately 66kDa, which is the molecular weight for MMP-14 in 
lane 3. The extra bands in lane 5 is likely due to protein degradation in untransfected 
HSC-3 cell lysate. Probing the blot with anti-β-actin antibody yielded 42kDa band sizes 
of equal sizes equivalent to the molecular size of actin across all the samples (Figure 
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14B). This shows that equal amount of protein (for all the samples) was loaded on the 
gel, and also that shRNA 2 gave a detectable reduction in MMP-14 protein levels. 
 
3.5 Analyzing MMP-14 knockdown in HSC-3 cells through RT-qPCR 
To further verify knockdown in the transfected HSC-3 clones, the samples were analyzed 
by RT-qPCR. The RT-qPCR was run on the purified total RNA from both the transiently 
transfected cells and the bulk transfected clones using the SybrGreen assay and Gapdh 
as the internal control (Figure 15). 
                    
Figure 15: Stable transfection with MMP-14 shRNA can knockdown MMP-14 expression. 
PCR run on MMP-14 clones was done with the Sybr Green dye using Gapdh as the internal 
control. The derived CT values were normalized to the reference, and the fold change was 
calculated relative to the normalized HSC-3 wt expression level that was set to 1. 
HSC-3wt; HSC-3 wild type,TKD-1-4; transiently transfected HSC-3 cells using shRNA constructs 
1-4 respectively,TGFP; transiently transfected HSC-3 cell using pmaxGFP, TSC; HSC-3 cell 
transiently transfected with scrambled control, SKD-1-2; stably transfected HSC-3 cells using 
shRNA constructs 1-2 and SSC; stably transfected HSC-3 cells using scrambled control. 
 
 
Figure 15 shows that MMP-14 expression was not reduced since the scrambled controls 
gave lower values than the MMP-14 shRNA constructs. Since the experiment was done 




3.6 Analysing the cell features in terms of MMP-2 and MMP-14 localization, 
gelatinolytic activities, migration and invasion 
 
Having overexpressed MMP-2ic and knocked down MMP-14, the effects were analysed 
by immunostaining (to check for the subcellular localization of the proteins and 
expression levels) and xCELLigence assay (for their migrative and invasive behavior). In 
situ zymography was carried out on a full-length version of MMP-2 (FL-MMP-2)* and 
empty vector to check for enzymatic activities. 
*Even though the FL-MMP-2 plasmid was transformed and purified by me, the actual transfection was 




3.6.1 Immunostaining and confocal microscopy for the expression levels and subcellular 
localization of MMP-2 and MMP-14 
Immunostaining was performed on all the cell clones by seeding 1x105 cells in 8-well 
chambered glass slides in which the cells were fixed (Figure 16). 
 
             
Figure 16 (A-E): Probing of MMP-2 overexpressing cell clones with specific antibodies revealed the 
subcellular localization of MMP-2 proteins. 
The subcellular localization of the MMP-2 and MMP-14 proteins was determined by fixing the cells with 
4% PFA. 
Panel A: HSC-3 wt; Panel B: full length MMP-2;Panel C: Intracellular MMP-2-1; Panel D: Intracellular MMP-
2-2; Panel E: Empty vector for MMP-2. 
Probing was done with anti-MMP-2 primary antibody (Abcam ab37150) (1:100) and Alexa Fluor® 488 
Goat anti-rabbit (Life Technologies® #A11034) secondary antibody(1:200). 
 
Figure 16 (A-E) shows the presence of weak and diffuse MMP-2 staining in HSC-3wt 
(panel A). Increased fluorescence activities were observed around the cell edges of the 
MMP-2fl and MMP-2-2ic (panels B&D) compared to wild-typeHSC-3, MMP-2-2ic and the 





                                
 
 
Figure 16 (F-H): Probing of MMP-14 knockdown cell clones with specific antibodies revealed their 
subcellular localization  
The subcellular localization of the MMP-14 proteins was determined by fixing the cells with 4% PFA. 
Panel F: MMP-14 knockdown clone 1; Panel G: MMP-14 knockdown clone 2; Panel H: MMP-14 scrambled 
control. 
Probing was done with an anti-MMP-14 primary antibody (Novus NB 110-57216) (1:400) and Alexa 
Fluor® 488 Goat anti-rabbit (Life Technologies® #A11034) secondary antibody (1:200) 
Confocal microscopy was used to analyze the cells for subcellular localization of the proteins which was 
observed as green fluorescence, using the 63x1.2 water objective lens. 
 
 
MMP-14 KD clones showed almost the same distribution of fluorescent patterns (panels 
F-H), with what looked like an accumulation of punctuated fluorescence around the 
edges. 
 
3.6.2 Investigation of gelatinolytic activity in FL-MMP-2 by in situ zymography 








Figure 17: Gelatinolytic activity was demonstrated in HSC-3 selected for the 
overexpression of FL-MMP-2 and cells transfected with the empty vector plasmid.  
In situ zymography was performed by seeding 1 x105 cells in an 8-well chambered glass slide 
coated with 100 µl 2% sucrose gel containing 2% DQ gelatin (Invitrogen D12054).  
Top panel (A): Serum-free medium, wells 1& 2; Middle panel(B): Empty vector clones; Bottom 
panel (C): Full length MMP-2 clones. 
The cells were incubated at 37°C after which they were analysed for gelatinolytic activity using 
63x 1.2 water objective on the confocal microscope. 
 
As shown in figure 17, the absence of green fluorescence indicates the absence of 
gelatinolytic  activity in the SFM, which contained no cells (Figure 17A). The empty 
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vector clone surprisingly displayed some gelatinolytic tendencies as indicated by the 
green cells (Figure 17 B) while the FL-MMP-2 clones showed anzymatic degradation of 
the DQ gelatin around the cells and in the nucleus (Figure 17 C).                 
        
3.7 Analysis of cell clones for proliferation, migration and invasion by xCELLigence 
assay 
 
Having overexpressed the full-length version of MMP-2 (FL-MMP-2) and intracellular 
MMP-2 (MMP-2ic), as well as knock down MMP-14 in HSC-3 cells, the behavior of these 
cell clones in terms of migration and invasion was studied with the xCELLigence assay 
method. 
 
3.7.1 Cell proliferation 
At the start of the analysis, it was important to determine the optical number of cells 
that would maintain the exponential growth phase over a long period of time. In order 
to achieve this, different number of the HSC-3 cell (100, 300, 1000, 3000, 10,000, 30,000 
and 100,000) were seeded in 100 µl complete growth medium in duplicates followed by 






















Figure 18: Optimal cell seeding density can be determined by the xCELLigence system. 
Different number of HSC-3cells were seeded in duplicate on the the E-16 plate, in 100 µl of 
complete growth medium and recorded for 50 hours. Impedance reading over time provided the 
cell index which increased with increase in proliferation.  
 
Figure 18 shows that the optimal seeding density that would maintain the HSC-3 cells in  
a viable state was 10,000 cells. This cell number was used subsequently to analyse the 
different cell clones for adherence and proliferation ( Figure 19). Since all the different 
cell clones were derived from the HSC-3wt cell, it was assumed that the same seeding 






Figure 19: Adhesion and proliferation profile for MMP-2 clones. 
10,000 cells in 100 µl of complete growth medium ( for the 8 different cell clones) were seeded  
in duplicates on the E-16 microplate following the equilibration of the plate wells with 50 µl 
medium and background reading and recorded for 24 hours. 
Plate well colour code: Red: HSC-3wt; Light green: FL-MMP-2; Blue: MMP-2-1ic; Pink: MMP-2-
2ic; Light blue: Empty vector. The cells were monitored for 48-96 hours on the xCELLigence 
machine. 
 
Figure 19 shows a similarity in the cell adhesion/proliferation pattern across the MMP-2 
cell clones, with the exception of the EV and MMP-2-1ic which seemed to have 
proliferated a little more slowly. 
 
Figure 20: Adhesion and proliferation profile for MMP-14 clones  
10,000 cells in 100 µl of complete growth medium ( for the 8 different cell clones) were seeded  
in duplicates on the E-16 microplate following the equilibration of the plate wells with 50 µl 
medium and background reading. The samples were recorded for 24 hours. 
Plate well colour code: Red: KD-1: Knockdown clone 1, Green: Knockdown clone 2 and Blue: 
Scramble control. The cells were monitored for 48-96 hours on the xCELLigence machine. 
 





3.7.2 Cell migration 
The migrative capabilities of the clones was further analyzed by creating a migrative 
profile in which the cells were seeded  on top of the membrane in serum-free medium 
and made to migrate to a more conducive environment with a chemoattractant (medium 
supplemented with 10% FBS) (Figure 21). 
 
     
Figure 21: MMP-2 cell clones could migrate across barriers 
Approximately 10,000 cells in 100 µl of SFM was seeded on the top chamber of the CIM-plate 
and  have been made to migrate towards the bottom chamber of the plate containing medium 
with a chemoattractant (FBS). 
 
Figure 21 shows varying migration patterns of the MMP-2 cell clones across the barrier 
relative to the HSC-3wt. Surprisingly, FL-MMP-2 and the MMP-2-2ic migration was 






Figure 22: MMP-14 cell clones could migrate across barriers 
Approximately 10,000 cells in 100 µl of SFM was seeded on the top chamber of the CIM-plate 
and  have been made to migrate towards the bottom chamber of the plate containing medium 
with a chemoattractant (FBS). 
 
Figure 22 shows that cell migration for the MMP-14 clones also follows the same pattern 









3.7.3 Cell invasion through Matrigel 
 





Figure 23: The MMP-2 cell clones could not invade matrigel over a 96 hour period. 
xCELLigence assay for the invasion of HSC-3 MMP-2 and MMP-14 knockdown clones across 
matrigel was carried out by seeding 10,000 cells (in 100 µl of SFM) on the top chamber of the 
CIM-16 plate. The impedance is measured when the cells invade the matrigel barrier to migrate 
towards the chemoattractant-containing bottom chamber medium of the CIM-plate. 
 
Figure 23 shows negligible cell indexes for all the cell clones. No invasion was observed 




Figure 24: The MMP-14 cell clones could not invade matrigel over a 96 hour period. 
xCELLigence assay for the invasion of HSC-3 MMP-2 and MMP-14 knockdown clones across 
matrigel was carried out by seeding 10,000 cells (in 100 µl of SFM) on the top chamber of the 
CIM-16 plate. The impedance is measured when the cells invade the matrigel barrier to migrate 




Figure 24 shows that there was no matrigel invasion by MMP-14 cell clones in the first 










Cancer can simply be defined as unregulated cell growth [104]. This definition, though 
very simplistic, has a much deeper meaning especially when one considers that when 
there is a loss of cell regulation, various pathologies can arise. Several factors can lead to 
cancer, but their survival is dependent on several factors which include sustaining of 
proliferative signalling, evasion of growth suppressors, activation of invasion and 
metastasis, enabling replicative immortality, induction of angiogenesis, resistance to cell 
death etc. [105] Cancers can arise from various types of cells, with the most common 
being carcinomas, which arise from epithelial cells [104]. Carcinomas account for more 
than 80% of cancer-related deaths and affect epithelial cell layer of the gastro intestinal 
tract, skin, mammary glands, pancreas, lung, liver, ovaries, gall bladder, urinary bladder 
etc [104]. Human Oral squamous cell carcinoma is the most common form of oral cancer. 
They are characterised by highly aggressive behaviour, metastasis to other sites and the 
prognosis is poor [55, 106]. 
Proteolytic enzymes have been shown to play key roles in tumor growth and invasion 
[77]. One of such group of enzymes are the matrix metalloproteinases [77], which have 
been implicated in cancer cell survival mostly due to their direct/indirect roles  in 
normal physiological processes such as tissue remodelling in wound healing, 
development etc. As a result of their roles within the extracellular matrix and beyond, 
they are also able to enhance cell migration and invasion; thus the machineries used in 
normal physiological processes become arsenals in pathologies.  
 
In this study, HSC-3 cells derived from human oral squamous cell carcinoma were used 
to study  the roles of intracellular MMP-2 (MMP-2ic) and MMP-14 proteins by the 
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overexpression of MMP-2 variants and knockdown of MMP-14.  This cell does not have 
any MMP-2 from the beginning, so for comparison, HSC-3 cells overexpressing full 
length MMP-2 (FL-MMP-2) was provided.  
 
4.1 Increasing MMP-2 expression in HSC-3 cells 
The expression level of MMP-2 in HSC-3 cells was first determined by Western blotting 
(Fig 7) in which the protein was not detectable in the sample both in the presence and 
absence of DTT. However, the positive control derived from conditioned fibroblast 
medium, showed the presence of the 72kDa MMP-2 protein and by this finding, it was 
assumed that the HSC-3 cells either do not endogenously express MMP-2 or they 
express very negligible amounts, making them good candidates for the overexpression 
of the protein. Expression plasmids for intracellular MMP-2 (Ex-Z5731-m02-MMP-2) 
and empty vector control (Ex-neg-M02) were purchased from GeneCopoeia™ USA and 
before use, they were amplified by transformation of E.coli DH5-α competent bacteria 
and purified. The presence of cDNA encoding intracellular MMP-2 (MMP-2ic) was 
verified by restriction enzyme digestion (Figure 8) and sequencing (Figure 9). Nde1 
restriction enzyme digestion successfully generated two fragments each in the MMP-2ic 
and EV plasmids, with the band sizes corresponding to the restriction sites in the 
digested plasmid and corresponding to the calculated fragment sizes deduced from the 
plasmid map (Table 1). The three bands of the undigested (control) plasmids is most 
likely due to the different conformations that plasmids could exist as; circular, 
supercoiled or linear which influence their migration on a gel and thus, the more 
compact supercoiled plasmids tends to migrate faster. As expected, the plasmid 
containing the MMP-2ic cDNA is larger than the EV plasmid. To further confirm the 
presence of the MMP-2ic cDNA, DNA sequencing was performed on the purified plasmid 
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and BLAST search of the resulting sequences on NCBI returned about 98% 
complementarity between the sequenced plasmids and MMP-2transcript version 2 
(encoding MMP-2ic) found in the database (Figure 9). In order to compare the 
intracellular version of the MMP-2 (MMP-2ic) with the full-length version (Ex-K3935-
m02; FL-MMP-2), the FL-MMP-2 plasmid was also amplified by transforming the E.coli 
DH5α competent bacteria and purified. 
 
The initial work to optimize the transfection protocol for the HSC-3 cells was performed 
and showed that Lipofectamine-2000 was the preferred transfection reagent and that 
the optimal concentration of the selection antibiotic, Geniticin (G418), should be 
400µg/ml. Generation of HSC-3 single cell clones overexpressing MMP-2ic was 
performed and provided for further analysis by a colleague. The conditioned medium 
from the cells clones were analyzed for MMP-2 activity by gelatin zymography (Figure 
10) and revealed that the MMP-2ic -overexpressing cells possessed gelatinolytic activity 
in bands with the size corresponding to MMP-2ic. No bands of that size were detected in 
the HSC-3-EV clones, further strengthening the assumption that the bands of 
approximately 42kDa corresponds to the overexpressed MMP-2ic (lanes 14 and 15). All 
clones also expressed pro-MMP-9 as bands of approximately 92kDa were also observed 
on the zymogram. Attempts to detect MMP-2ic expression by Western blotting on whole 
cell lysates proved futile (figure not shown). The fact that the protein was undetectable 
on Western blot, but detectable on the zymogram, albeit low amounts, confirms the 
sensitivity of zymography over western blotting, being able to detect as low as 10ρg 
amount of gelatinases. Again, the detection of the supposedly intracellulary 
overexpressed protein in conditioned serum-free medium, suggests some level of 
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secretion of the enzyme and also emphasizes the sensitivity of the method. Alternatively, 
the MMP-2ic is released into the medium from ruptured cells. 
 However, by virtue of this, it would have been a good idea to analyse the cell lysates by 
zymography in order to be able to truly ascertain if the lack of detection was due to very 
low amounts of the intracellular variant of the protein or its complete absence. Also, the 
total expression level of the MMP-2ic as shown on the zymogram, is not very strong on 
its own. It will not suffice to conclude at this point if the MMP-2ic protein was 
completely absent in the cell lysates, as some technical difficulties were encountered 
that also hindered the detection of the positive control. This could have been an 
antibiotic problem and the experiment should have been repeated a few more times. 
This could not be pursued due to time constraint. 
  
The overexpression was further verified by RT-qPCR and in order to eliminate any 
discrepancies in the result, the purified total RNAs from the stable transfection clones 
which had measured concentration of ≥100 ng/µl, were sent for integrity testing (Figure 
11A). The integrity testing result revealed that intact RNA (made up of the 28S and the 
18S ribosomal RNA) was present in most of the samples. Two of the RNA samples were 
degraded to some degree and were not proceeded with in the RT-qPCR analysis. The 
degradation of the RNA is most likely a result of the introduction of RNases into the 
samples during handling. This can be avoided by ensuring to a great extent that the lab 
is as RNase-free as possible. Another cause of degradation could be as a result of 
contaminated reagents and/or water, but this is not the case due to the fact that there is 




 RT-qPCR on the intact RNAs showed variation in the relative levels of of the MMP-2 
transcripts, when compared to one of the empty vector clones (EV-7) (Figure11B). The 
primers used do not discriminate between between the various MMP-2 variants, 
however, the increased transcript levels detected by the primers is most likely due to 
the presence of the MMP-2ic expression vector. The second clone, MMP-2-2ic, yielded 
the highest expression of MMP-2 with a fold change of 18. The variation in the MMP-2ic 
expression in the different clones could be attributed to the fact that plasmids taken up 
into a cell are able to incorporate into different positions and the more transcriptionally 
active the genomic region is, the more successful the expression of the incorporated 
vector. In order to resolve this and obtain almost identical protein expression across 
samples, generation of mixed clones could be employed. However, this is not a big 
problem in this case, since the idea was to obtain as much overexpression of the protein 
of interest as possible. 
 
4.2 Reduction of MMP-14 expression in HSC-3 cells 
Prior to MMP-14 knockdown, the HSC-3 cells were analysed for the inherent expression 
of the protein (Figure 12). Strong signals corresponding to the MMP-14 molecular 
weight of approximately 66kDa were detected, denoting that the cells had high amounts 
of the protein. Although an extra band was detected high up on the membrane, the main 
band was the same size as MMP-14. In order to verify the best shRNAs that would 
knockdown MMP-14, four different shRNA constructs were used to transiently transfect 
HSC-3 cells, after which equal protein concentrations were analysed by Western blotting 
(Figure 13A). The signal strengths of two of the constructs were relatively lower than 
the rest, indicating a successful knockdown in two of the clones (figure 13A). Probing for 
β-actin served as a loading control, in which equal bands signify that equal amount of 
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proteins were loaded on the gel (figure 13B). As a result of the successful knockdown, 
the constructs were used to stably transfect the HSC-3 cells, which again showed that 
MMP-14 expression was lowered using one of the shRNA constructs (Figure 14A); and 
with the equal actin bands, a knockdown could be said to have taken place (figure 14B).  
Although the main bands corresponded to the molecular weight of the 66kDa MMP-14 
protein, extra bands were observed on the membrane and these can be due to protein 
overload, which can be corrected by reducing the amount of loaded protein or it could 
be due to non-specific antibody binding.  The reduced band size with part of the band 
located lower down the membrane (Figure 14B, lane 5) for wild-type HSC-3 cell could be 
as a result of protein degradation. This occurs mostly due to repetitive freeze-thaw of 
the sample and can be avoided by using fresher samples. 
The use of RT-qPCR to confirm the knockdown of MMP-14 (Figure 15), showed that 
both transient and stable transfections let to knockdown in clones transfected with 
shRNA constructs 1, 2 and 3 relative to the wildtype HSC-3 cell. It was surprising that 
the transiently transfected HSC-3 (KD- 3) demonstrated a stronger knockdown effect 
than that detected by western blotting for transient transfection (Figure 13 A). Even 
more surprising is the lower expression of MMP-14 in both transient and stable 
transfections with the scrambled control in comparison to the untransfected wild-type 
cells. One way to explain these is possibly sample handling, which can be improved upon 
in subsequent experiments. Due to the time limit, these experiments were only 




4.3 Analysis of protein expression and subcellular localization by immunostaining and 
confocal microscopy  
Analyses of MMP-2 expression in the various clones by immunostaining and confocal 
microscopy (Figure 16) revealed that the HSC-3wt cells (panel A) had some weak and 
diffuse fluorescent activity although they were negative for MMP-2 in Western blot 
analysis. This could either be as a result of autofluorescence, very low amounts of MMP-
2 to which the primary antibody binds or non-specific binding of the primary/secondary 
antibody. These can be optimised by improving the blocking steps, using more specific 
antibodies and/or filtration during image acquisition. The FL-MMP-2 and MMP-2-2ic 
clones (panels B and D) showed some strong fluorescent activity around the cell edges, 
the invadopodia, while MMP-2-1ic cells (panel C) showed a more nuclear localization. 
The empty vector clone (panel E) showed diffuse fluorescent patterns possibly due to 
autofluorescence.  
The MMP-14 knockdown clones, KD-1 and KD-2 (Figure 16, panels F and G) showed 
some similarities in their fluorescent patterns and intensities with diffuse cytoplasmic 
localization and more punctuated fluorescent activity around the cell edges.  
MMP-14 SC clones showed some diffuse fluorescent patterns (panel H). The stronger 
signals observed in the knockdown clones is rather surprising, since weaker signals 
compared to those of the scrambled control were expected.  
This experiment though is inconclusive and must be repeated a few more times under 
more optimized conditions for clarity. 
 
In situ zymography analysis on FL-MMP-2 and EV (figure 17) clones showed some 
gelatinolytic activity which localized to the nucleus. The gelatinolytic activity on the 
empty vector clone was not quite expected. The reason for this is most likely due to the 
presence of other gelatinases in the cells, such as MMP-9 (as can be seen in the 
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zymogram from figure 10). Again, the overall gelatinolytic activity in the FL-MMP-2 
clone might not be solely due to MMP-2 activity and thus this finding is rather 
inconclusive and the experiment should be optimised, possibly by the inclusion of 
inhibitors in the experiments etc, and repeated before any conclusions can be drawn. 
The inclusion of a control with MMP-9 knockdown could be considered, although it is 
time consuming, it would go a long way in answering our questions. On a lighter note, 
the SFM control expectedly did not show any green cells. 
 
4.4 Comparison of the MMP-2 cell clones and MMP-14  cell clones by 
xCELLigence: proliferation, migration and matrigel invasion 
Cell migration and invasion studies by xCELLigence revealed a huge array of 
discrepancies. In the adhesion and proliferation assay (Figure 19), all the cell clones 
proliferated at almost the same rate with the exception of the empty vector clone and 
the MMP-2-1ic, which seemed to have fallen off from the pattern. A reason for this might 
be that the clones do not mimic the wild-type cell in their proliferative patterns, thus 
this should be ascertained separately for the individual clones. Another reason could be 
that less number of cells were seeded, thus the experiments should be repeated. 
 
The migration assay (Figure 20), was not as anticipated, yielding an awry array of 
unexpected patterns. The observed migration pattern was HSC-3 > KD-1 > SC > MMP-2-
2ic > KD-2 > FL-MMP-2 > MMP-2-1ic > EV whereas one would presume the pattern to be 
FL-MMP-2 > MMP-2-2ic > MMP-2-1ic >HSC-3wt > SC or EV > KD-1 or KD-2 since cells 
overexpressing for FL-MMP-2 were expected to migrate more than the rest and those 
knocked down for MMP-14 were expected to migrate far less. There is the possibility 
that the shRNA did not effectively knockdown the MMP-14. As can be seen from figure 
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16, the fold-change in MMP-14 expression in the clones with regards to that in the HSC-3 
wt cell was relatively low and almost insignificant. 
 
The invasion assay did not yield a promising result either since matrigel was not 
effectively invaded by any of the clones. It is possibly due to the thickness of the matrigel 
that could serve as a hindrance to invading cells, further diluting the matrigel could be 
very useful. Another fault could be with the experimental procedure, eg cell seeding 
errors would affect the proliferative behaviours of the cells. Trypsinization is also a 
factor to consider as over trypsinization of the cells would affect the cell surface 
receptors required for migration. Use of high passage number cells also influences their 
proliferation. Overall, the xCELLigence system is a very sensitive technique and care 
needs to be taken to optimise the experimental conditions. The results derived from the 
xCELLigence experiments are not conclusive since they have been done only a few 
number of times with non-reproducible results. However, for more certainty, the 
experiments have to be repeated many times over. 
 
5. CONCLUSION 
The matrix metalloproteinases -2 (MMP-2) and membrane type-1 matrix 
metalloproteinase (MT1-MMP) have been shown from previous studies, to interact in 
the promotion of tumor cell migration and invasion. The results from this study showed 
that HSC-3 cells were conducive for studying the MMP-2 variants and MMP-14 since 
they do not endogenously express MMP-2 but express high levels of MMP-14. Clones for 
the overexpression of the intracellular MMP-2, MMP-2ic, have been generated but more 
work would still need to be done for the verification of the MMP-14 knockdown. In 
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order to obtain more promising results, several stages have to be optimised such as: the 
use of alternative plasmids for MMP-2 overexpression and MMP-14 knockdown; the use 
of more specific antibodies for immunostaining; the inclusion of inhibitors as a control 
for in situ zymography; the individual determination of the proliferative patterns of cell 
clones in order to determine their optimal seeding densities and the optimisation of the 
xCELLigence experiments for reproducibility. The successful generation of MMP-14 
clones, in combination with the MMP-2 clones, would provide some useful tools for 
further studies on MMP-2 variants and MMP-14. In the long run, further cloning would 
have to be done for the combined manipulation of MMP-2 and MMP-14, which will 
provide cells that will pose useful for studying the interaction between the two proteins. 
The successful establishment of these methods would go a long way in the application of 
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Figure 1: Alignment of the sequences of the MMP-2 vector compared with human 
MMP-2, transcript variant 2 (Accession number NM 001127891).  
 
Sample 1: Forward Reaction 
 
Score Expect Identities Gaps Strand Frame 
2015 bits(1091) 0.0() 1149/1174(98%) 15/1174(1%) Plus/Plus  
Features: 
Query  38    CATGCAATACCTGAACACCTTCTATGGCTGCCCCAAGGAGAGCTGCAACCTGTTTGTGCT  97 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  314   CATGCAATACCTGAACACCTTCTATGGCTGCCCCAAGGAGAGCTGCAACCTGTTTGTGCT  373 
 
Query  98    GAAGGACACACTAAAGAAGATGCAGAAGTTCTTTGGACTGCCCCAGACAGGTGATCTTGA  157 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  374   GAAGGACACACTAAAGAAGATGCAGAAGTTCTTTGGACTGCCCCAGACAGGTGATCTTGA  433 
 
Query  158   CCAGAATACCATCGAGACCATGCGGAAGCCACGCTGCGGCAACCCAGATGTGGCCAACTA  217 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  434   CCAGAATACCATCGAGACCATGCGGAAGCCACGCTGCGGCAACCCAGATGTGGCCAACTA  493 
 
Query  218   CAACTTCTTCCCTCGCAAGCCCAAGTGGGACAAGAACCAGATCACATACAGGATCATTGG  277 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  494   CAACTTCTTCCCTCGCAAGCCCAAGTGGGACAAGAACCAGATCACATACAGGATCATTGG  553 
 
Query  278   CTACACACCTGATCTGGACCCAGAGACAGTGGATGATGCCTTTGCTCGTGCCTTCCAAGT  337 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  554   CTACACACCTGATCTGGACCCAGAGACAGTGGATGATGCCTTTGCTCGTGCCTTCCAAGT  613 
 
Query  338   CTGGAGCGATGTGACCCCACTGCGGTTTTCTCGAATCCATGATGGAGAGGCAGACATCAT  397 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  614   CTGGAGCGATGTGACCCCACTGCGGTTTTCTCGAATCCATGATGGAGAGGCAGACATCAT  673 
 
Query  398   GATCAACTTTGGCCGCTGGGAGCATGGCGATGGATACCCCTTTGACGGTAAGGACGGACT  457 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  674   GATCAACTTTGGCCGCTGGGAGCATGGCGATGGATACCCCTTTGACGGTAAGGACGGACT  733 
 
Query  458   CCTGGCTCATGCCTTCGCCCCAGGCACTGGTGTTGGGGGAGACTCCCATTTTGATGACGA  517 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  734   CCTGGCTCATGCCTTCGCCCCAGGCACTGGTGTTGGGGGAGACTCCCATTTTGATGACGA  793 
 
Query  518   TGAGCTATGGACCTTGGGAGAAGGCCAAGTGGTCCGTGTGAAGTATGGCAACGCCGATGG  577 
             |||||||||||||||||||||||||||||||||||||||||||||||| ||||||||||| 
Sbjct  794   TGAGCTATGGACCTTGGGAGAAGGCCAAGTGGTCCGTGTGAAGTATGGGAACGCCGATGG  853 
 
Query  578   GGAGTACTGCAAGTTCCCCTTCTTGTTCAATGGCAAGGAGTACAACAGCTGCACTGATAC  637 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  854   GGAGTACTGCAAGTTCCCCTTCTTGTTCAATGGCAAGGAGTACAACAGCTGCACTGATAC  913 
 
Query  638   CGGCCGCAGCGATGGCTTCCTCTGGTGCTCCACCACCTACAACTTTGAGAAGGATGGCAA  697 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  914   CGGCCGCAGCGATGGCTTCCTCTGGTGCTCCACCACCTACAACTTTGAGAAGGATGGCAA  973 
 
Query  698   GTACGGCTTCTGTCCCCATGAAGCCCTGTTCACCATGGGCGGCAACGCTGAAGGACAGCC  757 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
96 
 
Sbjct  974   GTACGGCTTCTGTCCCCATGAAGCCCTGTTCACCATGGGCGGCAACGCTGAAGGACAGCC  1033 
 
Query  758   CTGCAAGTTTCCATTCCGCTTCCAGGGCACATCCTATGACAGCTGCACCACTGAGGGCCG  817 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1034  CTGCAAGTTTCCATTCCGCTTCCAGGGCACATCCTATGACAGCTGCACCACTGAGGGCCG  1093 
 
Query  818   CACGGATGGCTACCGCTGGTGCGGCACCACTGAGGACTACGACCGCGACAAGAAGTATGG  877 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1094  CACGGATGGCTACCGCTGGTGCGGCACCACTGAGGACTACGACCGCGACAAGAAGTATGG  1153 
 
Query  878   CTTCTGCCCTGAGACCGCCATGTCCACTGTTGGTGGGAACTCAGAA-GTGCCCCCTGTGT  936 
             |||||||||||||||||||||||||||||||||||||||||||||| ||||||||||||| 
Sbjct  1154  CTTCTGCCCTGAGACCGCCATGTCCACTGTTGGTGGGAACTCAGAAGGTGCCCCCTGTGT  1213 
 
Query  937   CTTCCCCTTCACTTTCCTGGGCAACAAATATGAGAGCTGCACCAGCGCCGGCCGCAGTGA  996 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1214  CTTCCCCTTCACTTTCCTGGGCAACAAATATGAGAGCTGCACCAGCGCCGGCCGCAGTGA  1273 
 
Query  997   CGGAAAGATGTGGTGTGCGACCACAGCCAACTACGATGACGACCGCAAGTGGGGGCTTCT  1056 
             ||||||||||||||||||||||||||||||||||||||| |||||||||| ||||||||| 
Sbjct  1274  CGGAAAGATGTGGTGTGCGACCACAGCCAACTACGATGATGACCGCAAGT-GGGGCTTCT  1332 
 
Query  1057  GCCCTGACCAAAGGTACAGCCTGTTC-TCGT-GCAGCCCACGAGTTTGGGCACGGCATGG  1114 
             ||||||||||| |||||||||||||| |||| ||||||||||||||||| |||| ||||| 
Sbjct  1333  GCCCTGACCAAGGGTACAGCCTGTTCCTCGTGGCAGCCCACGAGTTTGGCCACGCCATGG  1392 
 
Query  1115  GGCT-GAGCACTCCCAGGACC-TGGGGACCCTGATG-CACCCATT-ACACTTAC-C-AGG  1168 
             |||| ||||||||||| |||| ||||| |||||||| |||||||| |||| ||| | | | 
Sbjct  1393  GGCTGGAGCACTCCCAAGACCCTGGGG-CCCTGATGGCACCCATTTACACCTACACCAAG  1451 
 
Query  1169  A-CTCCGGTCTGTCC-AGGATGAACACTCAAGGG  1200 
             | || | |||||||| ||||||| || ||||||| 
Sbjct  1452  AACTTCCGTCTGTCCCAGGATGA-CA-TCAAGGG  1483 
Sample 1: Reverse reaction 
 
 
Query  58    AGCT-AGCAGCCTAGCCAGTCGGATTTGATGCTTCCAAACTTCACGCTCTTCAGACTTTG  116 
             |||| ||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  2150  AGCTCAGCAGCCTAGCCAGTCGGATTTGATGCTTCCAAACTTCACGCTCTTCAGACTTTG  2091 
 
Query  117   GTTCTCCAGCTTCAGGTAATAGGCACCCTTGAAGAAGTAGCTGTGACCGCCGCCCTGCAG  176 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  2090  GTTCTCCAGCTTCAGGTAATAGGCACCCTTGAAGAAGTAGCTGTGACCGCCGCCCTGCAG  2031 
 
Query  177   GTCCACGACGGCATCCAGGTTATCGGGGATGGCATTCCAGGCATCTGCGATGAGCTTGGG  236 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  2030  GTCCACGACGGCATCCAGGTTATCGGGGATGGCATTCCAGGCATCTGCGATGAGCTTGGG  1971 
 
Query  237   AAAGCCAGGATCCATTTTCTTCTTCACCTCATTGTATCTCCAGAATTTGTCTCCAGCAAA  296 
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1970  GAAGCCAGGATCCATTTTCTTCTTCACCTCATTGTATCTCCAGAATTTGTCTCCAGCAAA  1911 
 
Query  297   GATGTATGTCTTCTTGTTTTTGCTCCAGTTAAAGGCGGCATCCACTCGCTGGACATCAGG  356 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1910  GATGTATGTCTTCTTGTTTTTGCTCCAGTTAAAGGCGGCATCCACTCGCTGGACATCAGG  1851 
 
Query  357   GGGCAGTCCCAGGCTGGTCAGTGGCTTGGGGTACCCTCGCTCCAGGGTGCTGGCTGAGTA  416 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1850  GGGCAGTCCCAGGCTGGTCAGTGGCTTGGGGTACCCTCGCTCCAGGGTGCTGGCTGAGTA  1791 
 
Query  417   GATCCAGTATTCATTCCCTGCAAAGAACACAGCCTTCTCCTCCTGTGGGGCCTCGTATAC  476 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1790  GATCCAGTATTCATTCCCTGCAAAGAACACAGCCTTCTCCTCCTGTGGGGCCTCGTATAC  1731 
 
Query  477   CGCATCAATCTTTTCCGGGAGCTCAGGCCAGAATGTGGCCACCAGCAGGGGCCCCATGGG  536 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 




Query  537   CTTGTCACGTGGCGTCACAGTCCGCCAAATGAACCGGTCCTTGAAGAAGAAGATCTCACC  596 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1670  CTTGTCACGTGGCGTCACAGTCCGCCAAATGAACCGGTCCTTGAAGAAGAAGATCTCACC  1611 
 
Query  597   ACGGATCTGAGCGATGCCATCAAATACAATGTCCTGTTTGCAGATCTCAGGAGTGACAGG  656 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1610  ACGGATCTGAGCGATGCCATCAAATACAATGTCCTGTTTGCAGATCTCAGGAGTGACAGG  1551 
 
Query  657   GCCCAGTGTGGGGGTGGGGCCGGTGCCAAGGTCAATGTCAGGAGAGGCCCCATAGAGCTC  716 
             |||||| ||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1550  GCCCAGCGTGGGGGTGGGGCCGGTGCCAAGGTCAATGTCAGGAGAGGCCCCATAGAGCTC  1491 
 
Query  717   CTGAATGCCCTTGATGTCATCCTGGGACAGACGGAAGTTCTTGGTGTAGGTGTAAATGGG  776 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1490  CTGAATGCCCTTGATGTCATCCTGGGACAGACGGAAGTTCTTGGTGTAGGTGTAAATGGG  1431 
 
Query  777   TGCCATCAGGGCCCCAGGGTCTTGGGAGTGCTCCAGCCCCATGGCGTGGCCAAACTCGTG  836 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1430  TGCCATCAGGGCCCCAGGGTCTTGGGAGTGCTCCAGCCCCATGGCGTGGCCAAACTCGTG  1371 
 
Query  837   GGCTGCCACGAGGAACAGGCTGTACCCTTGGTCAGGGCAGAAGCCCCACTTGCGGTCGTC  896 
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||| || 
Sbjct  1370  GGCTGCCACGAGGAACAGGCTGTACCCTTGGTCAGGGCAGAAGCCCCACTTGCGGTCATC  1311 
 
Query  897   ATCGTAGTTGGCTGTGGTCGCACACCACATCTTTCCGTCACTGCGGCCGGCGCTGGTGCA  956 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1310  ATCGTAGTTGGCTGTGGTCGCACACCACATCTTTCCGTCACTGCGGCCGGCGCTGGTGCA  1251 
 
Query  957   GCTCTCATATTTGTTGCCCAGGAAAGTGAATGGGAAGACACAGGGG-CACCTTTCTGAGT  1015 
             |||||||||||||||||||||||||||||| ||||||||||||||| |||| |||||||| 
Sbjct  1250  GCTCTCATATTTGTTGCCCAGGAAAGTGAAGGGGAAGACACAGGGGGCACC-TTCTGAGT  1192 
 
Query  1016  TCCCACCAACAGTGGACATGGCGGTCTCAGG-CAG-AGCCATACTTCTTGTCGCGGTCGT  1073 
             ||||||||||||||||||||||||||||||| ||| |||||||||||||||||||||||| 
Sbjct  1191  TCCCACCAACAGTGGACATGGCGGTCTCAGGGCAGAAGCCATACTTCTTGTCGCGGTCGT  1132 
 
Query  1074  AGTC-TCAGT-GTGCCGCACCAGCG-TAGCCATCCGTGCG-CCCTCAAT-GTGCAGCTGT  1128 
             |||| ||||| |||||||||||||| |||||||||||||| |||||| | |||||||||| 
Sbjct  1131  AGTCCTCAGTGGTGCCGCACCAGCGGTAGCCATCCGTGCGGCCCTCAGTGGTGCAGCTGT  1072 
 
Query  1129  CATAGGAATGTGCC-TGGA-GCG-A-TGGAAAACGTGCAG--CTGTCCT-CA-CGATG-C  1179 
             ||||||| |||||| |||| ||| | |||||| | |||||  ||||||| || || || | 
Sbjct  1071  CATAGGA-TGTGCCCTGGAAGCGGAATGGAAA-CTTGCAGGGCTGTCCTTCAGCGTTGCC  1014 
 
Query  1180  GCCAATGGTGAACAG  1194 
             ||| ||||||||||| 







Query  37    CATGCAATACCTGAACACCTTCTATGGCTGCCCCAAGGAGAGCTGCAACCTGTTTGTGCT  96 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  314   CATGCAATACCTGAACACCTTCTATGGCTGCCCCAAGGAGAGCTGCAACCTGTTTGTGCT  373 
 
Query  97    GAAGGACACACTAAAGAAGATGCAGAAGTTCTTTGGACTGCCCCAGACAGGTGATCTTGA  156 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  374   GAAGGACACACTAAAGAAGATGCAGAAGTTCTTTGGACTGCCCCAGACAGGTGATCTTGA  433 
 
Query  157   CCAGAATACCATCGAGACCATGCGGAAGCCACGCTGCGGCAACCCAGATGTGGCCAACTA  216 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  434   CCAGAATACCATCGAGACCATGCGGAAGCCACGCTGCGGCAACCCAGATGTGGCCAACTA  493 
 
Query  217   CAACTTCTTCCCTCGCAAGCCCAAGTGGGACAAGAACCAGATCACATACAGGATCATTGG  276 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 




Query  277   CTACACACCTGATCTGGACCCAGAGACAGTGGATGATGCCTTTGCTCGTGCCTTCCAAGT  336 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  554   CTACACACCTGATCTGGACCCAGAGACAGTGGATGATGCCTTTGCTCGTGCCTTCCAAGT  613 
 
Query  337   CTGGAGCGATGTGACCCCACTGCGGTTTTCTCGAATCCATGATGGAGAGGCAGACATCAT  396 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  614   CTGGAGCGATGTGACCCCACTGCGGTTTTCTCGAATCCATGATGGAGAGGCAGACATCAT  673 
 
Query  397   GATCAACTTTGGCCGCTGGGAGCATGGCGATGGATACCCCTTTGACGGTAAGGACGGACT  456 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  674   GATCAACTTTGGCCGCTGGGAGCATGGCGATGGATACCCCTTTGACGGTAAGGACGGACT  733 
 
Query  457   CCTGGCTCATGCCTTCGCCCCAGGCACTGGTGTTGGGGGAGACTCCCATTTTGATGACGA  516 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  734   CCTGGCTCATGCCTTCGCCCCAGGCACTGGTGTTGGGGGAGACTCCCATTTTGATGACGA  793 
 
Query  517   TGAGCTATGGACCTTGGGAGAAGGCCAAGTGGTCCGTGTGAAGTATGGCAACGCCGATGG  576 
             |||||||||||||||||||||||||||||||||||||||||||||||| ||||||||||| 
Sbjct  794   TGAGCTATGGACCTTGGGAGAAGGCCAAGTGGTCCGTGTGAAGTATGGGAACGCCGATGG  853 
 
Query  577   GGAGTACTGCAAGTTCCCCTTCTTGTTCAATGGCAAGGAGTACAACAGCTGCACTGATAC  636 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  854   GGAGTACTGCAAGTTCCCCTTCTTGTTCAATGGCAAGGAGTACAACAGCTGCACTGATAC  913 
 
Query  637   CGGCCGCAGCGATGGCTTCCTCTGGTGCTCCACCACCTACAACTTTGAGAAGGATGGCAA  696 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  914   CGGCCGCAGCGATGGCTTCCTCTGGTGCTCCACCACCTACAACTTTGAGAAGGATGGCAA  973 
 
Query  697   GTACGGCTTCTGTCCCCATGAAGCCCTGTTCACCATGGGCGGCAACGCTGAAGGACAGCC  756 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  974   GTACGGCTTCTGTCCCCATGAAGCCCTGTTCACCATGGGCGGCAACGCTGAAGGACAGCC  1033 
 
Query  757   CTGCAAGTTTCCATTCCGCTTCCAGGGCACATCCTATGACAGCTGCACCACTGAGGGCCG  816 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1034  CTGCAAGTTTCCATTCCGCTTCCAGGGCACATCCTATGACAGCTGCACCACTGAGGGCCG  1093 
 
Query  817   CACGGATGGCTACCGCTGGTGCGGCACCACTGAGGACTACGACCGCGACAAGAAGTATGG  876 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1094  CACGGATGGCTACCGCTGGTGCGGCACCACTGAGGACTACGACCGCGACAAGAAGTATGG  1153 
 
Query  877   CTTCTGCCCTGAGACCGCCATGTCCACTGTTGGTGGGAACTCAGAA-GTGCCCCCTGTGT  935 
             |||||||||||||||||||||||||||||||||||||||||||||| ||||||||||||| 
Sbjct  1154  CTTCTGCCCTGAGACCGCCATGTCCACTGTTGGTGGGAACTCAGAAGGTGCCCCCTGTGT  1213 
 
Query  936   CTTCCCCTTCACTTTCCTGGGC-ACAAATATGAGAGCTGCACCAGCGCCG-CCGCAGTGA  993 
             |||||||||||||||||||||| ||||||||||||||||||||||||||| ||||||||| 
Sbjct  1214  CTTCCCCTTCACTTTCCTGGGCAACAAATATGAGAGCTGCACCAGCGCCGGCCGCAGTGA  1273 
 
Query  994   CG-AAAGATGT-GTGTGCGACCACAGCC-ACTACGATGACGACCGCAAGTGGGGGCTTCT  1050 
             || |||||||| |||||||||||||||| |||||||||| |||||||||| ||||||||| 
Sbjct  1274  CGGAAAGATGTGGTGTGCGACCACAGCCAACTACGATGATGACCGCAAGT-GGGGCTTCT  1332 
 
Query  1051  GCCCTGACCAAGG-TACAGCCTGT-C-TCGT-GCAGCCCACGAG-TTGTCCACGCCATGG  1105 
             ||||||||||||| |||||||||| | |||| |||||||||||| ||| ||||||||||| 
Sbjct  1333  GCCCTGACCAAGGGTACAGCCTGTTCCTCGTGGCAGCCCACGAGTTTGGCCACGCCATGG  1392 
 
Query  1106  GGCTGGAGCACTCCCA-GAC--TGGGGC--TGATG-CACCC  1140 
             |||||||||||||||| |||  ||||||  ||||| ||||| 




Query  57    AGCT-AGCAGCCTAGCCAGTCGGATTTGATGCTTCCAAACTTCACGCTCTTCAGACTTTG  115 
             |||| ||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  2150  AGCTCAGCAGCCTAGCCAGTCGGATTTGATGCTTCCAAACTTCACGCTCTTCAGACTTTG  2091 
 
Query  116   GTTCTCCAGCTTCAGGTAATAGGCACCCTTGAAGAAGTAGCTGTGACCGCCGCCCTGCAG  175 
99 
 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  2090  GTTCTCCAGCTTCAGGTAATAGGCACCCTTGAAGAAGTAGCTGTGACCGCCGCCCTGCAG  2031 
 
Query  176   GTCCACGACGGCATCCAGGTTATCGGGGATGGCATTCCAGGCATCTGCGATGAGCTTGGG  235 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  2030  GTCCACGACGGCATCCAGGTTATCGGGGATGGCATTCCAGGCATCTGCGATGAGCTTGGG  1971 
 
Query  236   AAAGCCAGGATCCATTTTCTTCTTCACCTCATTGTATCTCCAGAATTTGTCTCCAGCAAA  295 
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1970  GAAGCCAGGATCCATTTTCTTCTTCACCTCATTGTATCTCCAGAATTTGTCTCCAGCAAA  1911 
 
Query  296   GATGTATGTCTTCTTGTTTTTGCTCCAGTTAAAGGCGGCATCCACTCGCTGGACATCAGG  355 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1910  GATGTATGTCTTCTTGTTTTTGCTCCAGTTAAAGGCGGCATCCACTCGCTGGACATCAGG  1851 
 
Query  356   GGGCAGTCCCAGGCTGGTCAGTGGCTTGGGGTACCCTCGCTCCAGGGTGCTGGCTGAGTA  415 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1850  GGGCAGTCCCAGGCTGGTCAGTGGCTTGGGGTACCCTCGCTCCAGGGTGCTGGCTGAGTA  1791 
 
Query  416   GATCCAGTATTCATTCCCTGCAAAGAACACAGCCTTCTCCTCCTGTGGGGCCTCGTATAC  475 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1790  GATCCAGTATTCATTCCCTGCAAAGAACACAGCCTTCTCCTCCTGTGGGGCCTCGTATAC  1731 
 
Query  476   CGCATCAATCTTTTCCGGGAGCTCAGGCCAGAATGTGGCCACCAGCAGGGGCCCCATGGG  535 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1730  CGCATCAATCTTTTCCGGGAGCTCAGGCCAGAATGTGGCCACCAGCAGGGGCCCCATGGG  1671 
 
Query  536   CTTGTCACGTGGCGTCACAGTCCGCCAAATGAACCGGTCCTTGAAGAAGAAGATCTCACC  595 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1670  CTTGTCACGTGGCGTCACAGTCCGCCAAATGAACCGGTCCTTGAAGAAGAAGATCTCACC  1611 
 
Query  596   ACGGATCTGAGCGATGCCATCAA---CAATGTCCTGTTTGCAGATCTCAGGAGTGACAGG  652 
             |||||||||||||||||||||||   |||||||||||||||||||||||||||||||||| 
Sbjct  1610  ACGGATCTGAGCGATGCCATCAAATACAATGTCCTGTTTGCAGATCTCAGGAGTGACAGG  1551 
 
Query  653   GCCCAGTGTGGGGGTGGGGCCGGTGCCAAGGTCAATGTCAGGAGAGGCCCCATAGAGCTC  712 
             |||||| ||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1550  GCCCAGCGTGGGGGTGGGGCCGGTGCCAAGGTCAATGTCAGGAGAGGCCCCATAGAGCTC  1491 
 
Query  713   CTGAATGCCCTTGATGTCATCCTGGGACAGACGGAAGTTCTTGGTGTAGGTGTAAATGGG  772 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1490  CTGAATGCCCTTGATGTCATCCTGGGACAGACGGAAGTTCTTGGTGTAGGTGTAAATGGG  1431 
 
Query  773   TGCCATCAGGGCCCCAGGGTCTTGGGAGTGCTCCAGCCCCATGGCGTGGCCAAACTCGTG  832 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1430  TGCCATCAGGGCCCCAGGGTCTTGGGAGTGCTCCAGCCCCATGGCGTGGCCAAACTCGTG  1371 
 
Query  833   GGCTGCCACGAGGAACAGGCTGTACCCTTGGTCAGGGCAGAAGCCCCACTTGCGGTCGTC  892 
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||| || 
Sbjct  1370  GGCTGCCACGAGGAACAGGCTGTACCCTTGGTCAGGGCAGAAGCCCCACTTGCGGTCATC  1311 
 
Query  893   ATCGTAGTTGGCTGTGGTCGCACACCACATCTTTCCGTCACTGCGGCCGGCGCTGGTGCA  952 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1310  ATCGTAGTTGGCTGTGGTCGCACACCACATCTTTCCGTCACTGCGGCCGGCGCTGGTGCA  1251 
 
Query  953   GCTCTCATATTTGTTGCCCAGGAAAGTGAAAGGGGAAGACACAGGGG-CACCTTCTGAGT  1011 
             |||||||||||||||||||||||||||||| |||||||||||||||| |||||||||||| 
Sbjct  1250  GCTCTCATATTTGTTGCCCAGGAAAGTGAA-GGGGAAGACACAGGGGGCACCTTCTGAGT  1192 
 
Query  1012  TCCCACCAACAGTGGACATGGCGGTCTCAG--CAGA-GCCATACTTTCTTGTCGCGGTCG  1068 
             ||||||||||||||||||||||||||||||  |||| ||||||| ||||||||||||||| 
Sbjct  1191  TCCCACCAACAGTGGACATGGCGGTCTCAGGGCAGAAGCCATAC-TTCTTGTCGCGGTCG  1133 
 
Query  1069  TAGTC-TCAGTGGTGCCGCACCAGCGGTTAGC-AT-CGTGCGTCCCTCAGTGA-GCAGCC  1124 
             ||||| |||||||||||||||||||||| ||| || |||||| |||||||||  |||||  
Sbjct  1132  TAGTCCTCAGTGGTGCCGCACCAGCGGT-AGCCATCCGTGCGGCCCTCAGTGGTGCAGC-  1075 
 
Query  1125  TTGTCATAGAATGTGCC-TG-A-GCGGGATTGGAAACCTGCAGC-CTGTTCCTTTCAAGC  1180 
100 
 
              |||||||| ||||||| || | |||| | ||||||| |||||  |||| |||| || || 
Sbjct  1074  -TGTCATAGGATGTGCCCTGGAAGCGGAA-TGGAAACTTGCAGGGCTGT-CCTT-CA-GC  1020 
 
Query  1181  GATTGACCGGCCC  1193 
             | ||| ||| ||| 
Sbjct  1019  G-TTG-CCG-CCC  1010 
 
 
101 
 
